| Sauvagine | Pyr-GPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2 |
| Biotin-ACTH (1-39), human | Biotin-SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
| ACTH (7-38), human | FRWGKPVGKKRRPVKVYPNGAEDESAEAFPLE |
| ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF |
| ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
| ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP |
| ACTH (1-17) | SYSMEHFRWGKPVGKKR |
| ACTH (1-10) | SYSMEHFRWG |
| Adrenomedullin (1-50), rat | YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY-NH2 (Disulfide bridge: 14-19) |
| Pramlintide, Acetate [Pro25, 28, 29]-Amylin(1-37), human, Amide | KCNTATCATQRLANFLVHSSNNFGPILPPTNVGSNTY-NH2 (S-S Bond) acetate salt |
| Biotin-Amylin (1-37), amide, human | Biotin-KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (disulfide bridge: 2-7) |
| Amylin (8-37), rat | ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 |
| Amylin (20-29), human | SNNFGAILSS |
| Amylin (1-37), rat, mouse | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 (Disulfide bridge: 2-7) |
| [NMeG24, NMeI26] Human Islet Amyloid Polypeptide (IAPP) (22-27) | NF-(NMe-G)-A-(NMe-I)-L |
| Beta-Amyloid (13-28), Human | HHQKLVFFAEDVGSNK |
| Beta-Amyloid (17-28), Human, mouse/rat | LVFFAEDVGSNK |
| [Pro18]-Beta-Amyloid (12-28); V8P Beta-Amyloid (12-28); Aβ12-28P, Human | VHHQKLPFFAEDVGSNK |
| Beta-Amyloid (12-28), Human | VHHQKLVFFAEDVGSNK |
| Beta-Amyloid (1-28)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNK-K(Biotin)-NH2 |
| Beta-Amyloid (1-28), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNK |
| Beta-Amyloid (1-40), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (1-40) • HCl, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV • HCl |
| Beta-Amyloid (1-40) • HFIP, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV • HFIP |
| Beta-Amyloid Peptide (1-40), mouse, rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Scrambled-beta-Amyloid (1-40), Human | AEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA |
| Beta-Amyloid (40-1), Human | VVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD |
| Biotin-beta-Amyloid (1-40), Human | Biotin-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Biotin-LC-beta-Amyloid (1-40), Human | Biotin-LC-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (1-40)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(Biotin)-NH2 |
| Beta-Amyloid (1-40)-Lys(Biotin-LC), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(Biotin-LC) |
| Beta-Amyloid (1-40)-Lys(LC-biotin)-NH2, FAM-labeled, Human | 5-FAM-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(LC-BIOTIN)-NH2 |
| Beta-Amyloid (1-40)-Lys(Biotin)-NH2, mouse, rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV-K(Biotin)-NH2 |
| Beta-Amyloid (1-40), FAM-labeled, Human | FAM-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (1-40), TAMRA-labeled, Human | TAMRA-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Cys-beta-Amyloid (1-40), Human | CDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (1-40)-Cys, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVC |
| [Arg6]-beta-Amyloid (1-40), English Mutation, Human | DAEFRRDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| [Asn7]-beta-Amyloid (1-40), Tottori-Japanese Mutation, Human | DAEFRHNSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| [Gly21]-beta-Amyloid (1-40), A21G, Flemish Mutation, Human | DAEFRHDSGYEVHHQKLVFFGEDVGSNKGAIIGLMVGGVV |
| [Gln22]-beta-Amyloid (1-40), Dutch Mutation, Human | DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV |
| [Gln22, Asn23]-beta-Amyloid (1-40), E22Q/D23N Dutch/Iowa double mutation, Human | DAEFRHDSGYEVHHQKLVFFAQNVGSNKGAIIGLMVGGVV |
| [Gly22]-beta-Amyloid (1-40), Arctic Mutation, Human | DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV |
| [Lys22]-beta-Amyloid (1 - 40), Italian Mutation, Human | DAEFRHDSGYEVHHQKLVFFAKDVGSNKGAIIGLMVGGVV |
| [Asn23]-beta-Amyloid (1-40), Iowa Mutation, Human | DAEFRHDSGYEVHHQKLVFFAENVGSNKGAIIGLMVGGVV |
| [Cys26]-beta-Amyloid (1-40), S26C beta-Amyloid (1-40), Human | DAEFRHDSGYEVHHQKLVFFAEDVGCNKGAIIGLMVGGVV |
| Beta-Amyloid (2-40), Human | AEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (3-40), Human | EFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| [Pyr3]-beta-Amyloid (3-40), Human | Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (11-40), Human | EVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (11-40), FAM-labeled, Human | 5-FAM-EVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (17-40), Human, mouse/rat | LVFFAEDVGSNKGAIIGLMVGGVV |
| Biotin-beta-Amyloid (17-40), Human, mouse/rat | Biotin-LVFFAEDVGSNKGAIIGLMVGGVV |
| Beta-Amyloid (1-40) Binding Peptide, Biotin-labeled | Biotin-DWGKGGRWRLWPGASGKTEA |
| Beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (1-42) • HCl, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA • HCl |
| Biotin-beta-Amyloid (1-42), Human | Biotin-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Biotin-LC-beta-Amyloid (1-42), Human | Biotin-LC-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (1-42)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA-K(Biotin)-NH2 |
| Beta-Amyloid (1-42) • HFIP, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA • HFIP |
| Beta-Amyloid (1-42), sodium salt, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid Peptide (1-42), mouse, rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Cys-beta-Amyloid (1-42), Human | CDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Scrambled-beta-Amyloid (1-42), Human | AIAEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA |
| Beta-Amyloid (1-42), Scrambled, 5-FAM labeled, Human | 5-FAM-AIAEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA |
| Beta-Amyloid (42-1), Human | AIVVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD |
| Beta-Amyloid (1-42), FAM-labeled, Human | FAM-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| [Met]-beta-Amyloid (1-42), 5-TAMRA labeled, Human | 5-TAMRA-MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| [Arg6]-beta-Amyloid (1-42), English Mutation, Human | DAEFRRDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| [Asn7]-beta-Amyloid (1-42), Tottori-Japanese Mutation, Human | DAEFRHNSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| [Pro19]-beta-Amyloid (1-42); F19P beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVPFAEDVGSNKGAIIGLMVGGVVIA |
| [Gly21]-beta-Amyloid (1-42), A21G Flemish Mutation, Human | DAEFRHDSGYEVHHQKLVFFGEDVGSNKGAIIGLMVGGVVIA |
| [Gln22]-beta-Amyloid (1-42), E22Q Dutch Mutation, Human | DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVVIA |
| [Gly22]-beta-Amyloid (1-42), E22G Arctic Mutation, Human | DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVVIA |
| [Lys22]-beta-Amyloid (1-42), Italian Mutation, Human | DAEFRHDSGYEVHHQKLVFFAKDVGSNKGAIIGLMVGGVVIA |
| [Asn23]-beta-amyloid (1-42), Iowa Mutation, Human | DAEFRHDSGYEVHHQKLVFFAENVGSNKGAIIGLMVGGVVIA |
| [Cys26]-beta-Amyloid (1-42), S26C beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVFFAEDVGCNKGAIIGLMVGGVVIA |
| [Met(O)35]-beta-Amyloid (1-42), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-M(O)-VGGVVIA |
| Beta-Amyloid (2-42), Human | AEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (3-42), Human | EFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| [Pyr3]-beta-Amyloid (3-42), Human | Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (4-42), Human | FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (5-42), Human | RHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (9-42), Human | GYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (11-42), Human | EVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| [Pyr11]-beta-Amyloid (11-42), Human | Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (20-42), Human, mouse/rat | FAEDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (22-42), Human, mouse/rat | EDVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (23-42), Human, mouse/rat | DVGSNKGAIIGLMVGGVVIA |
| Beta-Amyloid (1-9), Human | DAEFRHDSG |
| Beta-Amyloid (1-10), Human | DAEFRHDSGY |
| Beta-Amyloid (1-11), Human | DAEFRHDSGYE |
| Beta-Amyloid (1-12), Human | DAEFRHDSGYEV |
| Beta-Amyloid (1-13), Human | DAEFRHDSGYEVH |
| Beta-Amyloid (1-15), Human | DAEFRHDSGYEVHHQ |
| Beta-Amyloid (1-16), Human | DAEFRHDSGYEVHHQK |
| Beta-Amyloid (1-16)-Lys(Biotin-LC)-NH2, Human | DAEFRHDSGYEVHHQK-K(Biotin-LC)-NH2 |
| Beta-Amyloid (1-17), Human | DAEFRHDSGYEVHHQKL |
| Beta-Amyloid (1-17)-Cys, Human | DAEFRHDSGYEVHHQKLC |
| Beta-Amyloid (1-22), Human | DAEFRHDSGYEVHHQKLVFFAE |
| Beta-Amyloid (1-33), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIG |
| Beta-Amyloid (1-34), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL |
| Beta-Amyloid (1-36), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMV |
| Beta-Amyloid (1-37), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVG |
| Beta-Amyloid (1-38), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGG |
| Beta-Amyloid (1-39), Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGV |
| Beta-Amyloid (3-16), Human | EFRHDSGYEVHHQK |
| Beta-Amyloid (10-20), Human | YEVHHQKLVFF |
| Beta-Amyloid (10-26), Human | YEVHHQKLVFFAEDVGS |
| Beta-Amyloid (10-35)-Lys(Biotin)-NH2, Human | YEVHHQKLVFFAEDVGSNKGAIIGLM-K(Biotin)-NH2 |
| Beta-Amyloid (11-17), Human | EVHHQKL |
| Beta-Amyloid (11-22), Human | EVHHQKLVFFAE |
| Beta-Amyloid (11-25), Human | EVHHQKLVFFAEDVG |
| Biotin-LC-beta-Amyloid (15-25), Human, mouse/rat | Biotin-LC-QKLVFFAEDVG |
| Beta-Amyloid (16-22), Human, mouse/rat | KLVFFAE |
| Beta-Amyloid (17-24), Human, mouse/rat | LVFFAEDV |
| Beta-Amyloid (22-35), Human, mouse/rat | EDVGSNKGAIIGLM |
| Biotin-LC-beta-Amyloid (22-41), Human, mouse/rat | Biotin-LC-EDVGSNKGAIIGLMVGGVVI |
| Beta-Amyloid (25-35), Human, mouse/rat | GSNKGAIIGLM |
| Angiotensin (1-7) | DRVYIHP |
| Beta-Amyloid (25-35) • HCl, Human, mouse/rat | GSNKGAIIGLM • HCl |
| Beta-Amyloid (25-35), scrambled, Human, mouse/rat | MAKGINGISGL |
| Biotin-beta-Amyloid (25-35), Human, mouse/rat | Biotin-GSNKGAIIGLM |
| Beta-Amyloid (1-28)-Lys(Biotin)-NH2, Human | DAEFRHDSGYEVHHQKLVFFAEDVGSNK-K(Biotin) NH2 |
| Angiotensin II, human | DRVYIHPF |
| Angiotensin II, human, FAM-labeled | FAM-DRVYIHPF |
| Angiotensin II, human, TAMRA-labeled | TAMRA-DRVYIHPF |
| Biotin-LC-Angiotensin II | Biotin-LC-DRVYIHPF |
| Angiotensin II Substrate | DRV-pY-IHPF |
| Angiotensin I, human | DRVYIHPFHL |
| Angiotensin I Converting Enzyme 2, (ACE-2) Substrate | Mca-APK(Dnp) |
| Angiotensin I Converting Enzyme 2, ACE-2/Caspase-1 Substrate | Mca-YVADAPK(Dnp) |
| Angiotensin III | RVYIHPF |
| Tetradecapeptide Renin Substrate, Angiotensinogen (1-14), rat | DRVYIHPFHLLYYS |
| Rat Renin Inhibitor Peptide, WFML Peptide | Ac-HPFV-(Sta)-LF-NH2 |
| Renin 390 FRET Substrate I | R-E(EDANS)-IHPFHLVIHT-K(DABCYL)-R |
| Calcitonin Gene Related Peptide, CGRP, human | ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 (Disulfide bridge: 2-7) |
| C-Type Natriuretic Peptide (32-53), human, porcine | GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: 6-22) |
| BNP-45, mouse | SQGSTLRVQQRPQNSKVTHISSCFGHKIDRIGSVSRLGCNALKLL (Disulfide bridge:23-39) |
| BNP-32, human | SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: 10-26) |
| Biotin-Oxytocin | Biotin-CYIQNCPLG-NH2 (Disulfide bridge: 1-6) |
| Big Endothelin-1 (1-38), human | CSCSSLMDKECVYFCHLDIIWVNTPEHVVPYGLGSPRS (Disulfide bridge: 1-15 and 3-11) |
| Big Endothelin 1 (1-39), porcine | CSCSSLMDKECVYFCHLDIIWVNTPEHIVPYGLGSPSRS (Disulfide bridge: 1-15 and 3-11) |
| Bactenecin, bovine | RLCRIVVIRVCR (Disulfide bridge: 3-11) |
| Atrial Natriuretic Peptide (4-18), rat | RSSCFGGRIDRIGAC-NH2 (Disulfide bridge 4-15) |
| Atrial Natriuretic Peptide (1-28), rat | SLRRSSCFGGRIDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23) |
| Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled | Biotin-SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23) |
| Apamin | CNCKAPETALCARRCQQH-NH2 (Disulfide bridge: 1-11; 3-15) |
| Atrial Natriuretic Peptide (1-28), human, porcine | SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23) |
| Amylin (1-37), human, amide | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (Disulfide bridge: 2-7) |
| Amylin (1-37), human | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY (Disulfide bridge: 2-7) |
| Adrenomedullin (1-52), human | YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: 16-21) |
| [Arg8]-Vasopressin (AVP) | CYFQNCPRG-NH2 (Disulfide bridge: 1-6) |
| α-Calcitonin Gene Related Peptide, α-CGRP, rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge: 2-7) |
| Temporin L, amide | FVQWFSKFLGRIL-NH2 |
| Temporin A, amide | FLPLIGRVLSGIL-NH2 |
| SMAP 29, Sheep Myeloid Antimicrobial Peptide 29 | RGLRRLGRKIAHGVKKYGPTVLRIIRIAG |
| rCRAMP | GLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ |
| Pyrrhocoricin | VDKGSYLPRPTPPRPIYNRN |
| Protegrine-1 (PG-1), amide | RGGRLCYCRRRFCVCVGR-NH2 (disulfide bridge:6-15 and 8-13) |
| mCRAMP, mouse | GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ |
| Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS |
| Magainin 1 | GIGKFLHSAGKFGKAFVGEIMKS |
| LL17-32 | FKRIVQRIKDFLRNLV |
| LL17-29 | FKRIVQRIKDFLR |
| LL-37, scrambled | GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR |
| LL-37, reverse sequence | SETRPVLNRLFDKIRQVIRKFEKGIKEKSKRFFDGLL |
| LL-37, Antimicrobial Peptide, human | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| LL-37 fragment (18-37), LL-18-37 | KRIVQRIKDFLRNLVPRTES |
| LEAP-1, Hepcidin, human | DTHFPICIFCCGCCHRSKCGMCCKT (Disulfide bridges: 7-23, 10-13, 11-19, 14-22) |
| Lactoferricin B, Lactoferrin (17-41) | FKCRRWQWRMKKLGAPSITCVRRAF (S-S BOND) |
| Indolicidin | ILPWKWPWWPWRR-NH2 |
| Human Lactotransferrin (37-61), Lactoferricin H | TKCFQWQRNMRKVR-G-PPVSCIKRDS (Disulfide between Cys3 and Cys20) |
| Histatin-5 | DSHAKRHHGYKRKFHEKHHSHRGY |
| HEL (46-61) | NTDGSTDYGILQINSR |
| Drosocin | GKPRPYSPRPTSHPRPIRV |
| Dermcidin, DCD-1L | SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL |
| Cys-LC-LL-37 | C-LC-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| CSP-2, Competence-Stimulating Peptide-2 | EMRISRIILDFLFLRKK |
| Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2 |
| Elafin | AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ (Disufide bonds between Cys16- Cys45, Cys23-Cys49, Cys32-Cys44, Cys38-Cys53) |
| Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2 |
| CAP-18, rabbit | GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY |
| Biotin-LC-LL-37 | Biotin-LC-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| Bac2A; Bactenecin 2A | RLARIVVIRVAR-NH2 |
| Apidaecin IB | GNNRPVYIPQPRPPHPRL |
| 5-FAM-LC-LL-37 | 5-FAM-LC-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| β-CGRP, human | ACNTATCVTHRLAGLLSRSGGMVKSNFVPTNVGSKAF-NH2 (Disulfide bridge:2-7) |
| [Ala13]-Apelin-13 | QRPRLSHKGPMPA |
| [Des-Arg10]-HOE I40 | rRP-Hyp-G-Thi-S-(D-Tic)-Oic |
| [Des-Pro2]-Bradykinin; Angiotensin I Converting Enzyme (ACE I) Inhibitor | RPPGFSPFR |
| [Lys0]-Bradykinin (Kallidin) | KRPPGFSPFR |
| [Lys8,9]-Neurotensin (8-13) | KKPYIL |
| [Pyr1]-Apelin-13 | Pyr-RPRLSHKGPMPF-OH |
| Apelin 12 | RPRLSHKGPMPF |
| Apelin-16, human, bovine | FRRQRPRLSHKGPMPF |
| Apelin-36, human | LVQPRGSRNGPGPWQGGRRKFRRQRPRLSHKGPMPF |
| Biotin-a-CGRP, human | Biotin-LC-ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 (Disulfide bridge:2-7) |
| Biotin-Bradykinin | Biotin-RPPGFSPFR |
| BNP-45 (51-95), rat, 5K Cardiac Natriuretic Peptide | SQDSAFRIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF (Disulfide bridge:23-39) |
| Calcitonin Gene Related Peptide, CGRP (8-37), human | VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 |
| EMP17, FITC-LC labeled | FITC-LC-TYSCHFGPLTWVCKPQGG |
| Endothelin 1, human, FAM-labeled | FAM-CSCSSLMDKECVYFCHLDIIW (Disulfide bridge: 1-15 and 3-11) |
| Endothelin 1, human, porcine | CSCSSLMDKECVYFCHLDIIW (Disulfide bridge: 1-15 and 3-11) |
| Endothelin 3, human, rat | CTCFTYKDKECVYYCHLDIIW (Disulfide bridge: 1-15 and 3-11) |
| Erythropoietin-Mimetic Peptide 17 (EMP17) | TYSCHFGPLTWVCKPQGG |
| Fibrinogen Binding Inhibitor Peptide | HHLGGAKQAGDV |
| Fibrinolysis Inhibiting Factor | GPRP |
| Fibrinopeptide A, human | ADSGEGDFLAEGGGVR |
| Fibrinopeptide B, human | Pyr-GVNDNEEGFFSAR |
| FRETS - VWF73 (Fluorescence-Quenching Substrate for ADAMTS-13) | DRE-Dap(Nma)-APNLVYMVTG-Dpa-PASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQR |
| Gamma - Fibrinogen (377-395) | YSMKETTMKIIPFNRLSIG |
| Gamma - Fibrinogen (377-395), scrambled | KMMISYTFPIERTGLISNK |
| H-D-Phe-Pro-Arg-AFC | fPR-AFC |
| H-D-Val-Leu-Lys-AFC | vLK-AFC |
| Hirudin (54-65), sulfated | Ac-GDFEEIPEE-Y(SO3H)-LQ |
| HOE I40 | rRP-(Hyp)-G-(Thi)-S-(D-Tic)-(Oic)-R |
| LSKL, Inhibitor of Thrombospondin (TSP-1) | LSKL-NH2 |
| Neurotensin | Pyr-LYENKPRRPYIL |
| Neurotensin (8-13) | RRPYIL |
| Proadrenomedullin N - terminal 20 peptide, PAMP (1-20) | ARLDVASEFRKKWNKWALSR-NH2 |
| Protease-Activated Receptor-1, PAR-1 Agonist | TFLLRN |
| Protease-Activated Receptor-1, PAR-1 Agonist, amide | AF(para-Fluoro)R-Cha-Cit-Y-NH2 |
| Protease-Activated Receptor-1, PAR-1 Antagonist | YFLLRNP-OH |
| Protease-Activated Receptor-1, PAR-1 Antagonist, amide | S-F(para-Fluoro)-Aad-LRNP-NH2 |
| Protease-Activated Receptor-2, PAR-2 Agonist, amide | 2-Furoyl-LIGRLO-NH2 |
| Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 |
| Protease-Activated Receptor-3 (1-6), PAR-3 (1-6), human | TFRGAP-NH2 |
| Protease-Activated Receptor-3, PAR-3 Agonist, amide | SFNGGP-NH2 |
| Protease-Activated Receptor-4, PAR-4 Agonist, amide | AYPGKF-NH2 |
| Protease-Activated Receptor-4, PAR-4 Agonist, amide, murine | GYPGKF-NH2 |
| Protease-Activated Receptor-4, PAR-4 Antagonist, amide | trans-Cinnamoyl-YPGKF-NH2 |
| RYR2 (2460-2495) | GFCPDHKAAMVLFLDRVYGIEVQDFLLHLLEVGFLP |
| Uroguanylin (Rat) | TDECELCINVACTGC (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15 |
| VIP (1-12), human, porcine, rat | HSDAVFTDNYTR |
| VIP, human, porcine, rat | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
| VIP, human, porcine, rat, FAM-labeled | FAM-HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
| WP9QY, TNF-alpha Antagonist | YCWSQYLCY (Disulfide bridge: 2-8) |
| Linear C5a Receptor Antagonist, human, rat | FKP-(D-Cha)-Wr |
| C5a Receptor Agonist, mouse, human | FKP-(D-Cha)-Cha-r |
| BMAP-18 | GRFKRFRKKFKKLFKKLS |
| BMAP-27 | GRFKRFRKKFKKLFKKLSPVIPLLHLG |
| NRC-16 | GWKKWLRKGAKHLGQAAIK |
| PMAP-23 | RIIDLLWRVRRPQKPKFVTVWVR |
| Rev4 | RRWPWWPWKWPLI |
| SMAP-18 | RGLRRLGRKIAHGVKKYG-NH2 |
| Tet-20 | KRWRIRVRVIRKC |
| Bax BH3 peptide (55-74), wild type | STKKLSECLKRIGDELDSNM |
| Biotin-Caspase 1 Inhibitor II | Biotin-YVAD-CMK |
| Caspase 1 (ICE) Substrate 2, chromogenic | Ac-YVAD-pNA |
| Caspase 1 (ICE) Substrate 3f, fluorogenic | Ac-WEHD-AFC |
| Caspase 1 Inhibitor II | Ac-YVAD-CMK |
| Caspase 3 (Apopain) Substrate 1, chromogenic | Ac-DEVD-pNA |
| Caspase 3 (Apopain) Substrate 1f, fluorogenic | Ac-DEVD-AFC |
| Caspase 3 (Apopain) Substrate 1m, fluorogenic | Ac-DEVD-AMC |
| Caspase 3 (Apopain) Substrate 1r-z, fluorogenic | (Z-DEVD)2-Rh110 |
| Caspase 8 Substrate 1, chromogenic | Ac-IETD-pNA |
| Caspase 8 Substrate 1f, fluorogenic | Ac-IETD-AFC |
| Caspase 9 Substrate 1, chromogenic | Ac-LEHD-pNA |
| Caspase 9 Substrate 1f, fluorogenic | Ac-LEHD-AFC |
| Pro-apoptotic Peptide, klaklakklaklak, 5-FAM-labeled | 5-FAM-klaklakklaklak-NH2 |
| Proapoptotic Peptide, (klaklak)2 | klaklakklaklak-NH2 |
| PUMA BH3 | EEQWAREIGAQLRRMADDLNAQYER |
| Smac/Diablo Peptide [AVPIAQKSE], 5-FAM labeled | AVPIAQKSEK-K(5-FAM)-NH2 |
| 26Rfa, Hypothalamic Peptide, human | TSGPLGNLAEELNGYSRKKGGFSFRF-NH2 |
| 26Rfa, Hypothalamic Peptide, rat | ASGPLGTLAEELSSYSRRKGGFSFRF-NH2 |
| CRAMP1-39 | ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ |
| Listeria monocytogenes Listeriolysin O; LLO (91-99) | GYKDGNEYI |
| Bacterial Sortase Substrate I, FRET | DABCYL-LPETG-EDANS |
| Bacterial Sortase Substrate II , Dabcyl/Edans | Dabcyl-QALPETGEE-Edans |
| Bacterial Sortase Substrate III, Abz/DNP | Abz-LPETG-K(Dnp)-NH2 |
| CFP10 (71-85) | EISTNIRQAGVQYSR |
| CSP-1, Competence Stimulating Peptide-1 | EMRLSKFFRDFILQRKK |
| flg22, Flagellin Fragment | QRLSTGSRINSAKDDAAGLQIA |
| HCAM-2 | 6-FAM-VFDAVTDVIIKNNLKECGLY |
| SPase I FRET Substrate | Dabcyl-AGHDAHASET-Edans |
| Staphylococcal Enterotoxin B Domain (SEB) (144-153) | KKKVTAQELD |
| bFGF (119-126), Basic Fibroblast Growth Factor, human, bovine | KRTGQYKL |
| BAD (103-127), human | NLWAAQRYGRELRRMSDEFVDSFKK |
| BAD (103-127), human, FAM-labeled | FAM-NLWAAQRYGRELRRMSDEFVDSFKK |
| Noxa BH3, Peptide 1 | PAELEVECATQLRRFGDKLNFRQKLL |
| [D-Tyr6, β-Ala11, Phe13, Nle14]-Bombesin (6-14) | yQWAV-(ß-A)-HF-Nle-NH2 |
| [Lys3]-Bombesin | Pyr-QKLGNQWAVGHLM-NH2 |
| C-peptide (57-87), human | EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ |
| C-peptide, dog | EVEDLQVRDVELAGAPGEGGLQPLALEGALQ |
| C-Peptide-1, rat | EVEDPQVPQLELGGGPEAGDLQTLALEVARQ |
| C-Peptide-2, rat | EVEDPQVAQLELGGGPGAGDLQTLALEVARQ |
| Proinsulin C-Peptide (31-63), porcine | RREAENPQAGAVELGGGLGGLQALALEGPPQKR |
| Proinsulin C-peptide (55-89), human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR |
| [Trp63, 64]-C3a (63-77) | WWGKKYRASKLGLAR |
| C3a (70-77) | ASHLGLAR |
| Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (Disulfide bridge: 1-7) |
| Calcitonin, salmon | CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2 (Disulfide bridge: 1-7) |
| [Asp370]-Tyrosinase (368-376) | YMDGTMSQV |
| AH1 Sequence (6-14) | SPSYVYHQF |
| Bak BH3 | GQVGRQLAIIGDDINR |
| Bak BH3 peptide, TAMRA-labeled | 5-TAMRA-GQVGRQLAIIGDDINR |
| Bcl-2 Binding Peptide, Bad BH3 Peptide | LWAAQRYGRELRRMSDEFEGSFKGL |
| Bid BH3 Peptide | EDIIRNIARHLAQVGDSMDR |
| Bid BH3, FAM labeled | 5-FAM-EDIIRNIARHLAQVGDSMDR |
| Bid BH3-r8 | rrrrrrrr-GEDIIRNIARHLAQVGDSMDR |
| Bim BH3, Peptide III | DMRPEIWIAQELRRIGDEFNAYYAR |
| Bim BH3, Peptide IV | DMRPEIWIAQELRRIGDEFNAYYARR |
| c-Myc peptide epitope | EQKLISEEDL |
| Enhanced Green Fluorescent Protein, EGFP (200-208) | HYLSTQSAL |
| G209-2M, gp100 (209-217) | IMDQVPFSV |
| GAD65 (206-220) | TYEIAPVFVLLEYVT |
| gp100 (25-33), human | KVPRNQDWL |
| HIF-1 {alpha} (556-574) | DLDLEMLAPYIPMDDDFQL |
| Kisspeptin-10 (Kp-10), Metastin (110-119), amide, mouse, rat | YNWNSFGLRY-NH2 |
| Kisspeptin-10 (Kp-10), Metastin (45-54) | YNWNSFGLRF-NH2 |
| LyP-1, Peptide 1 | CGNKRTRGC (S-S Bonded) |
| MAGE-3 (271-279) | FLWGPRALV |
| MUC1, tandem repeat fragment | PDTRPAPGSTAPPAHGVTSA |
| MUC5AC, Analog 1 | GTTPSPVPTTSTTSAP |
| MUC5AC 3 | GT-T*-PSPVPTTSTTSAP |
| MUC5AC-13 | GTTPSPVPTTST-T*-SAP |
| MUC5AC-3/13 | GT-T*-PSPVPTTST-T*-SAP |
| Noxa A BH3 peptide, cell permeable | rrrrrrrrGAELPPEFAAQLRKIGDKVYC |
| Nuclear Factor (Erythroid-derived 2)like 2 (74-87); Nrf2 (74-87); NFE2L2 (74-87) | LQLDEETGEFLPIQ |
| Shepherdin (79-87) | KHSSGCAFL |
| Thrombospondin-derived Peptide; Cyclic CSVTCG | CSVTCG (S-S Bonded) |
| TRP-2 (180-188) | SVYDFFVWL |
| TRP-2, Tyrosinase-related Protein 2 (181-188) | VYDFFVWL |
| VEGFR2/KDR Antagonist | ATWLPPR |
| β-Casomorphin (1-7), bovine | YPFPGPI |
| CEF1, Influenza Matrix Protein M1 (58-66) | GILGFVFTL |
| CEF2, Influenza Virus PA (46-54) | FMYSDFHFI |
| CEF8, Influenza Virus NP (383-391) | SRYWAIRTR |
| CEF10, Epstein-Barr Virus LMP2 (426-434) | CLGGLLTMV |
| CEF11, Epstein-Barr Virus BMLF1 (280-288) | GLCTLVAML |
| CEF19, Epstein-Barr Virus latent NA-3A (458-466) | YPLHEQHGM |
| CEF20, Cytomegalovirus, CMV pp65 (495-503) | NLVPMVATV |
| CEF25, Influenza Virus NP (44-52) | CTELKLSDY |
| CEF26, Influenza Virus NP (265-274) | ILRGSVAHK |
| CEF30, Epstein-Barr Virus BRLF1 (134-142) | ATIGTAMYK |
| 37,43Gap 27, Connexin Mimetic | SRPTEKTIFII |
| 37, 40 GAP26, Connexin Mimetic | VCYDQAFPISHIR |
| 40Gap 27, Connexin Mimetic | SRPTEKNVFIV |
| 43Gap 26, Connexin Mimetic | VCYDKSFPISHVR |
| 4N1K | KRFYVVMWKK |
| Cell Adhesive Peptide [RGDC] | RGDC |
| FN-A208 Fusion Peptide | GRGDSGAASIKVAVSADR |
| Gap 27, scrambled | REKIITSFIPT |
| Hyaluronan Inhibitor | GAHWQFNALTVR |
| Hyaluronan-Binding Peptide, biotin labeled | GAHWQFNALTVRGGGS-K(Biotin) |
| Vitronectin (367-378) | GKKQRFRHRNRKG |
| (Arg)9 | RRRRRRRRR |
| (Arg)9 biotin labeled | Biotin-LC-RRRRRRRRR-NH2 |
| (Arg)9, FAM-labeled | FAM-RRRRRRRRR |
| (Arg)9, TAMRA-labeled | TAMRA-RRRRRRRRR |
| Antennapedia Peptide, acid | RQIKIWFQNRRMKWKK |
| Antennapedia Peptide, FAM-labeled | 5-FAM-RQIKIWFQNRRMKWKK-NH2 |
| Anti-BetaGamma (MPS-Phosducin-like protein C terminus) | AAVALLPAVLLALLAVTDQLGEDFFAVDLEAFLQEFGLLPEKE |
| Biotin-TAT (47-57) | Biotin-YGRKKRRQRRR |
| Buforin | TRSSRAGLQFPVGRVHRLLRK |
| Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) | YTIWMPENPRPGTPCDIFTNSRGKRASNGGGGRRRRRRRRR |
| Cys(Npys) Antennapedia Peptide, amide | C(Npys)-RQIKIWFQNRRMKWKK-NH2 |
| Cys(Npys)-(Arg)9 | C(Npys)RRRRRRRRR-NH2 |
| Cys(Npys)-(D-Arg)9 | C(Npys)rrrrrrrrr-NH2 |
| Cys(Npys)-TAT (47-57) | C(Npys)YGRKKRRQRRR-NH2 |
| Cys(Npys)-TAT (47-57), FAM-labeled | C(Npys)YGRKKRRQRRR-K(FAM)-NH2 |
| Cys-TAT (47-57) | CYGRKKRRQRRR-NH2 |
| FITC-LC-Antennapedia Peptide | FITC-LC-RQIKIWFQNRRMKWKK-NH2 |
| FITC-LC-TAT (47-57) | FITC-LC-YGRKKRRQRRR-NH2 |
| HIV-1 Tat (48-60) | GRKKRRQRRRPPQ |
| KALA | WEAKLAKALAKALAKHLAKALAKALKACEA |
| Mastoparan | INLKALAALAKKIL-NH2 |
| NGR Peptide 1 | CNGRCGGklaklakklaklak-NH2 (Disulfide bridge: 1-5) |
| Penetratin | RQIKIWFQNRRMKWKKGG |
| Penetratin-Arg | RQIRIWFQNRRMRWRR |
| Pep-1-Cysteamine | Ac-KETWWETWWTEWSQPKKKRKV-cysteamine |
| Pep-1: Chariot (Non-Covalent Delivery of Peptides and Proteins) | KETWWETWWTEWSQPKKKRKV |
| pVEC (Cadherin-5) | LLIILRRRIRKQAHAHSK |
| Rabies Virus Glycoprotein (RVG) | YTIWMPENPRPGTPCDIFTNSRGKRASNG |
| SV-40 Large T-antigen Nuclear Localization Signal (NLS) | CGGGPKKKRKVED |
| SV40 T-Ag-derived Nuclear Localization Signal (NLS) Peptide | PKKKRKVEDPYC |
| TAT (47-57) | YGRKKRRQRRR |
| TAT (47-57) GGG-Cys(Npys) | YGRKKRRQRRRGGG-C(Npys)-NH2 |
| TAT (47-57), FAM-labeled | FAM-YGRKKRRQRRR |
| TAT (47-57), TAMRA-labeled | TAMRA-YGRKKRRQRRR |
| Tat-Beclin-1 | YGRKKRRQRRRGGTNVFNATFEIWHDGEFGT |
| Tat-Beclin-1, scrambled | YGRKKRRQRRRGGVGNDFFINHETTGFATEW |
| Tat-C (48-57) | CGRKKRRQRRR |
| TAT-GluR23A Fusion Peptide | YGRKKRRQRRRAKEGANVAG |
| Tat-GluR23Y | YGRKKRRQRRRYKEGYNVYG |
| Tat-GluR23Y, scrambled | YGRKKRRQRRRVYKYGGYNE |
| TAT-HA2 Fusion Peptide | RRRQRRKKRGGDIMGEWGNEIFGAIAGFLG |
| Tat-NR2Bct | YGRKKRRQRRRKLSSIESDV |
| TAT-NSF222 Fusion Peptide | YGRKKRRQRRR-GGG LDKEFNSIFRRAFASRVFPPE |
| TAT-NSF222scr Fusion Polypeptide, scrambled | YGRKKRRQRRR-GGG-ENSFRFLADIFPAKAFPVRFE |
| TAT-NSF700 Fusion Peptide | YGRKKRRQRRR-GGG-LLDYVPIGPRFSNLVLQALLVL |
| TAT-NSF700scr | YGRKKRRQRRRGGGIPPVYFSRLDLNLVVLLLAQL |
| TfR Targeting Peptide | THRPPMWSPVWP |
| Transdermal Peptide | ACSSSPSKHCG |
| Transportan | GWTLNSAGYLLGKINLKALAALAKKIL |
| Chemerin (149-157) | YFPGQFAFS |
| [Thr28, Nle31]-Cholecystokinin (25-33), sulfated | RD-Y(SO3H)-TGW-Nle-DF-NH2 |
| Caerulein | Pyr-QD-Y(SO3H)-TGWMDF-NH2 |
| Cholecystokinin (26-33), CCK Octapeptide, CCK-8, sulfated | D-Y(SO3H)-MGWMDF-NH2 |
| Cholecystokinin (26-33), CCK8 | DYMGWMDF-NH2 |
| Angiotensin I, human, 13C and 15N-labeled | DRVY-I*-HPFHL [I*=I(U13C6,15N)] |
| Angiotensin I, human, 13C and 15N labeled | DR-V*-Y-I*-HPFHL [Val*=Val(U-13C5,15N); Ile*=Ile(U-13C6,15N)] |
| Angiotensin II, human, 13C and 15N-labeled | DRVY-I*-HPF [I*=I(U13C6,15N)] |
| beta-Amyloid (1-38), 13C-Phe & Ile, Human | DAEFRHDSGYEVHHQKLV - *F - *F - AEDVGSNKGA-*I-*I-GLMVGG *F=Phe(U - 13C9), *I=Ile(U-13C6) |
| beta-Amyloid (1-40), 13C,15N-labeled at Arg & Lys, Human | DAEF - R* - HDSGYEVHHQ-K*-LVFFAEDVGSN-K*-GAIIGLMVGGVV [R*=R(U-13C6, U-15N4) & K*=K(U-13C6, U-15N2)] |
| beta-Amyloid (1-42), 13C, 15N-labeled at Arg & Lys, Human | DAEF-R*-HDSGYEVHHQ-K*-LVFFAEDVGSN-K*-GAIIGLMVGGVVIA [R*=R(U-13C6, U-15N4) & K*=K(U-13C6, U-15N2)] |
| BSA (347-359), Isotopic labeled, Mass Spec Standard | DAF-L*-GSF-L*-YEYSR [L*=L(U13C6, 15N)] |
| Biotin-Corticotropin Releasing Factor, Biotin - CRF, human, rat | Biotin-SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
| Corticotropin Releasing Factor, CRF, human, rat | SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
| Corticotropin Releasing Factor, CRF, ovine | SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2 |
| (Biotin-LC)-SARS-CoV-2 Spike RBM (receptor binding motif), 438-458 | Biotin-LC-SNNLDSKVGGNYNYLYRLFRK |
| Spike glycoprotein from SARS-CoV-2 | Spike glycoprotein from SARS-CoV-2 |
| DX 600, ACE2 Inhibitor | Ac-GDYSHCSPLRYYPWWKCTYPDPEGGG-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 319-335 | RVQPTESIVRFPNITNL |
| SARS - CoV - 2 Spike RBD (receptor binding domain), 319-335-Lys(Biotin-LC) | RVQPTESIVRFPNITNL-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 336-347 | CPFGEVFNATRF |
| SARS - CoV - 2 Spike RBD (receptor binding domain), 336-347-Lys(Biotin-LC) | CPFGEVFNATRF-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 348-357 | ASVYAWNRKR |
| SARS - CoV - 2 Spike RBD (receptor binding domain), 348-357-Lys(Biotin-LC) | ASVYAWNRKR-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 352-365 | AWNRKRISNCVADY |
| SARS - CoV - 2 Spike RBD (receptor binding domain), 352-365-Lys(Biotin-LC) | AWNRKRISNCVADY-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 371-394 | SASFSTFKCYGVSPTKLNDLCFTN |
| SARS-CoV-2 Spike RBD (receptor binding domain), 371-394-Lys(Biotin-LC) | SASFSTFKCYGVSPTKLNDLCFTN-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 395-430 | VYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT |
| SARS-CoV-2 Spike RBD (receptor binding domain), 395-430-Lys(Biotin-LC) | VYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFT-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 513-520 | LSFELLHA |
| SARS-CoV-2 Spike RBD (receptor binding domain), 513-520-Lys(Biotin-LC) | LSFELLHA-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBD (receptor binding domain), 523-541 | TVCGPKKSTNLVKNKCVNF |
| SARS-CoV-2 Spike RBD (receptor binding domain), 523-541-Lys(Biotin-LC) | TVCGPKKSTNLVKNKCVNF-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBM (receptor binding motif), 438-458 | SNNLDSKVGGNYNYLYRLFRK |
| SARS-CoV-2 Spike RBM (receptor binding motif), 450-473 | NYLYRLFRKSNLKPFERDISTEIY |
| SARS-CoV-2 Spike RBM (receptor binding motif), 450-473-Lys(Biotin-LC) | NYLYRLFRKSNLKPFERDISTEIY-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBM (receptor binding motif), 480-496 | CNGVEGFNCYFPLQSYG |
| SARS - CoV - 2 Spike RBM (receptor binding motif), 480-496-Lys(Biotin-LC) | CNGVEGFNCYFPLQSYG-K(Biotin-LC)-NH2 |
| SARS-CoV-2 Spike RBM (receptor binding motif), 500-509 | TNGVGYQPYR |
| SARS-CoV-2 Spike RBM (receptor binding motif), 500-509-Lys(Biotin-LC) | TNGVGYQPYR-K(Biotin-LC)-NH2 |
| Cyclo (-GRGDSP) | GRGDSP, N to C cyclized |
| Cyclo (-RADfK-), RGD negative control | Cyclo(-RADfK-) |
| Cyclo (-RGDyK) | Cyclo(-RGDyK) |
| Cyclo (RGDfC), avb3 Integrin Binding Cyclic RGD Peptide | Cyclo(-RGDfC) |
| Cyclo-[GRGESP] | Cyclo-[GRGESP] |
| Cyclo[-RGDy-K(5-FAM)] | Cyclo[-RGDy-K(5-FAM)] |
| Aminopeptidase N Ligand (CD13), NGR peptide | CNGRCG (Disulfide bridge: 1-5) |
| hBD-1, β-Defensin-1, human | DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK (Disulfide bridge: 5-34, 12-27, 17-35) |
| Charybdotoxin | Pyr-FTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS (Disulfide bridge: 7-28, 13-33 and 17-35) |
| Chlorotoxin (Cltx) | MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR-NH2 (Disulfide bridge: 2-19,5-28,16-33,20-35) |
| hBD-3, β-Defensin-3, human | GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK (Disulfide bridge: 11-40, 18-33, 23-41) |
| HNP-1, Defensin Human Neutrophil Peptide-1 | ACYCRIPACIAGERRYGTCIYQGRLWAFCC (Disulfide bridge: 2-30, 4-19, 9-29) |
| HNP-2, Defensin Human Neutrophil Peptide-2 | CYCRIPACIAGERRYGTCIYQGRLWAFCC (Disulfide bridge: 1-29, 3-18, 8-28) |
| Iberiotoxin (IbTX) | Pyr-FTDVDCSVSKECWSVCKDLFGVDRGKCMGKKCRCYQ(Disulfide bridge: C7-C28,C13-C33,C17-C35) |
| Orexin A, bovine, human, mouse, rat | Pyr-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (Disulfide bridge: 6-12 and 7-14) |
| RGD-4C | ACDCRGDCFCG (Disulfide bridge: 2-10 and 4-8) |
| Somatostatin 14, human, rat, mouse, pig, chicken, frog | AGCKNFFWKTFTSC (Disulfide bridge: 3-14) |
| Somatostatin 28, human, sheep, cow, rat, mouse, pig | SANSNPAMAPRERKAGCKNFFWKTFTSC (Disulfide bridge: 17-28) |
| MCC (88-103) | ANERADLIAYLKQATK |
| PCC (88-104) | KAERADLIAYLKQATAK |
| CHRG01; Human β-Defensin 3 (hBD3) Derivative | KSSTRGRKSSRRKK |
| Deltorphin A | YmFHLMD-NH2 |
| Deltorphin B | YaFEVVG-NH2 |
| [FAM-Trp31]-GLP-1 (7-36), Fluorescent label at Trp31 | HAEGTFTSDVSSYLEGQAAKEFIA (Trp-S-FAM)-LVKGR-NH2 |
| BDC2.5 Mimotope | RTRPLWVRME |
| Biotin-Exendin 4 | Biotin - HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Biotin-Glucagon (1-29), bovine, human, porcine | Biotin-HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
| Biotin-Glucagon-Like Peptide 1, GLP-1 (7-36), amide, human | Biotin-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| Exendin (5-39) | TFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin 4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin 4, FAM-labeled | FAM-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Fluorescein-Trp25-Exendin-4 (FLEX) | HGEGTFTSDLSKQMEEEAVRLFIE-(Trp-S-FAM)-LKNGGPSSGAPPPS-NH2 |
| GIP (1-42), human | YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
| GIP (3-42), human | EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
| GIP, rat | YAEGTFISDYSIAMDKIRQQDFVNWLLAQKGKKNDWKHNLTQ |
| GLP-1(9-36), amide, human | EGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| GLP-2 (1-34), Glucagon-Like Peptide-2 (1-34), human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR |
| Glucagon (1-29), bovine, human, porcine | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
| Glucagon (1-29), bovine, human, porcine, FAM-labeled | FAM-HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
| Glucagon (1-37), Oxyntomodulin, porcine | HSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNKNNIA |
| Glucagon-Like Peptide 1, GLP-1 (7-36), amide, human | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| Glucagon-Like Peptide 1, GLP-1 (7-36)-Lys(Biotin), amide, human | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRK(Biotin)-NH2 |
| Glucagon-Like Peptide 1, GLP-1 (7-37) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
| Glucagon-Like Peptide 1, GLP-1 amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| Glucagon-Like Peptide 1, GLP-1 amide, human, FAM-labeled | FAM-HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| IGRP Catalytic Subunit-related Protein (206-214) | VYLKTNVFL |
| Insulin β Chain Peptide (15-23) | LYLVCGERG |
| Insulin B (9-23) | SHLVEALYLVCGERG |
| Pancreatic Polypeptide, human | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 |
| Peptide YY (3-36), human | IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
| Peptide YY, human | YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
| Trp Cage | NLYIQWLKDGGPSSGRPPPS |
| Biotin-Dynorphin A (1-17) | Biotin-YGGFLRRIRPKLKWDNQ |
| Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ |
| Dynorphin A (1-8), porcine | YGGFLRRI |
| β-Endorphin, human | YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE |
| Autocamtide-2-Related Inhibitory Peptide (AIP); CaMKII Inhibitor, myristoylated | Myr-KKALRRQEAVDAL |
| Autocamtide-3 Derived Inhibitory Peptide(AC3-I); CaMKII Inhibitor, myristoylated | Myr-KKALHRQEAVDAL |
| Calpain Substrate, Fluorogenic | (Z-AA)2Rh110 |
| Cathepsin S Substrate | Ac-KQKLR-AMC |
| delta PKC (8-17); PKC d Inhibitor | SFNSYELGSL |
| Elastase Substrate, fluorogenic | (Z-AAAA)2Rh110 |
| Elastase/Trypsin Substrate, fluorogenic | (Z-AR)2Rh110•HCl |
| Enterokinase Substrate | GDDDDK-βNA |
| gp91 ds-tat | YGRKKRRQRRRCSTRIRRQL-NH2 |
| gp91 ds-tat Peptide 2 | RKKRRQRRRCSTRIRRQL-NH2 |
| gp91 ds-tat Peptide 2; sgp91 ds-tat Peptide 2, scrambled | RKKRRQRRRCLRITRQSR-NH2 |
| gp91 ds-tat, FAM labeled | 5-FAM-YGRKKRRQRRRCSTRIRRQL-NH2 |
| gp91 ds-tat; sgp91 ds-tat, scrambled | YGRKKRRQRRRCLRITRQSR-NH2 |
| IRAK-1 (360-380); IRAK-4 Peptide Substrate | KKARFSRFAGSSPSQSSMVAR |
| Mucin 10 (153-165), EA2 | PTTDSTTPAPTTK |
| O-linked GlcNAc transferase (OGT) Substrate | KKKYPGGSTPVSSANMM |
| Proteases Substrate, Fluorogenic | (Z-R)2Rh110 • 2HCl |
| S2238, Thrombin Substrate | f-Pip-R-pNA |
| α1(I) Collagen (614-639), Type I Collagen α1(I) C-Telopeptide, human | SAGFDFSFLPQPPQEKAHDGGRYYRA |
| Laminin α1 (2110-2127), amide, mouse | CSRARKQAASIKVAVSADR-NH2 |
| [Glu1]-Fibrinopeptide B | Glufib |
| [Glu3]-RGES, Control for RGD Peptides | RGES |
| GRGDS, amide | GRGDS-NH2 |
| GRGDS, LC-biotin labeled | Biotin-LC-GRGDS |
| Integrin Binding Peptide | Ac-GCGYGRGDSPG-NH2 |
| 390 MMP FRET Substrate I | Mca-PLGL-Dpa-AR-NH2 |
| 2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL | EDANS-CO-CH2-CH2-CO-ALERMFLSFP-Dap(DABCYL)OH |
| 390 MMP FRET Substrate II | Mca-PLGL-Dpa-AR |
| 390 MMP FRET Substrate IV | Mca-P-Cha-G-Nva-HA-Dpa-NH2 |
| 390 MMP FRET Substrate V | Mca-PLGLEEA-Dpa-NH2 |
| 490 MMP FRET Substrate III | DABCYL-RPLALWRS-EDANS |
| 5-FAM MMP FRET Peptide Fluorescence Standard I | 5-FAM-PL |
| 5-FAM-PMDM6 (PMDM6-F) | 5-FAM-(β-A)-(β-A)-FM-Aib-pY-(6-Cl-DL-Trp)-E-Ac3c-LN-NH2 |
| Abltide, TAMRA-labeled | 5-TAMRA-KKGEAIYAAPFA-NH2 |
| Cls Substrate, C2 (Abz/Dnp) | 2Abz-SLGRKIQIK(Dnp)-NH2 |
| CREBtide [KRREILSRRPSYR], 5-FAM labeled | 5-FAM-KRREILSRRPSYR |
| Crosstide [GRPRTSSFAEG], 5-FAM labeled | 5-FAM-GRPRTSSFAEG |
| CSK tide, FAM labeled | 5-FAM-KKKKEEIYFFFG-NH2 |
| EGF Receptor Substrate 2 [DADE-pY-LIPQQG], 5-FAM labeled | 5-FAM-DADE-pY-LIPQQG |
| HCV Protease FRET Substrate (RET S1) | Ac-DE-D(Edans)-EE-Abu-ψ-[COO]-AS-K(Dabcyl)-NH2 |
| Histone H1-derived Peptide, FAM-labeled | 5-FAM-GGGPATPKKAKKL |
| Histone H3 (1-21), K4 methylated, FAM labeled | ART-K(Me)-QTARKSTGGKAPRKQLAGG-K(FAM)-NH2 |
| HIV Protease FRET Substrate I | DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS |
| Kemptide [LRRASLG], 5-FAM labeled | 5-FAM-LRRASLG |
| MMP Colorimetric Substrate I | Ac-PLG-SCH[CH2CH(CH3)2]-CO-LG-OC2H5 |
| NFF-3 | Mca-RPKPVE-Nva-WR-K(Dnp)-NH2 |
| p53 (17-26), FITC labeled | FITC-LC-ETFSDLWKLL-NH2 |
| SAM PEP 1, FAM labeled; AMPK substrate peptide, FAM labeled | 5-FAM-HMRSAMSGLHLVKRR |
| Substance P, FAM-labeled | FAM-RPKPQQFFGLM-NH2 |
| TNO211 | DABCYL-(γ-Abu)-PQGL-E(EDANS)AK-NH2 |
| Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-TMR labeled | 5-TMR-KVEKIGEGTYGVVYK |
| WAAG-3R, Aggrecanase (ADAM-TS-4) FRET Substrate | Abz-TEGEARGSVI-Dpa-KK-NH2 |
| Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS |
| (Leu15)-Gastrin-1, human | Pyr-GPWLEEEEEAYGWLDF-NH2 |
| Big Gastrin-1, human | Pyr-LGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF-NH2 |
| Biotin-Gastrin (1-17) | Biotin-EGPWLEEEEEAYGWMDF-NH2 |
| Gastrin Releasing Peptide, human | VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 |
| Gastrin-1, human | Pyr-GPWLEEEEEAYGWMDF-NH2 |
| Gastrin-1, rat | Pyr-RPPMEEEEEAYGWMDF-NH2 |
| Leptin (93-105), human | NVIQISNDLENLR |
| [Des-octanoyl]-Ghrelin, human | GSSFLSPEHQRVQQRKESKKPPAKLQPR |
| [Des-octanoyl]-Ghrelin, rat, mouse | GSSFLSPEHQKAQQRKESKKPPAKLQPR |
| Biotin-Ghrelin, human | Biotin-GS-S(n-octanoyl)-FLSPEHQRVQQRKESKKPPAKLQPR |
| Ghrelin, human | GS-S(n-octanoyl)-FLSPEHQRVQQRKESKKPPAKLQPR |
| Ghrelin, rat, mouse | GS-S(n-octanoyl)-FLSPEHQKAQQRKESKKPPAKLQPR |
| α-Gliadin (31-43) | LGQQQPFPPQQPY |
| α9-Gliadin (57-68) | QLQPFPQPQLPY |
| α-Mating Factor Pheromone, yeast | WHWLQLKPGQPMY |
| Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
| [Leu31, Pro34]-Neuropeptide Y, human, rat | YPSKPDNPGEDAPAEDMARYYSALRHYINLLTRPRY-NH2 |
| Neuropeptide Y, human, rat | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
| Oxytocin | CYIQNCPLG-NH2 (Disulfide bridge: 1-6) |
| Biotin-PACAP (1-38), amide, human, ovine, rat | Biotin-HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP (1-27), amide, human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 |
| PACAP (1-38), amide, human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP (1-38)-Lys(Biotin), amide, human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNKK(Biotin)-NH2 |
| PACAP (6-38), amide, human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 |
| [Succinyl-Asp6, NMePhe8]-Substance P (6-11), Senktide | Suc-DF-(NMeF)-GLM-NH2 |
| Substance P | RPKPQQFFGLM-NH2 |
| BMP-2 Knuckle Epitope (73-92) | KIPKASSVPTELSAISTLYL |
| EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated | Biotin-DADE-pY-LIPQQG |
| EGFR Protein Tyrosine Kinase Substrate | ADEYLIPQQ |
| Growth Hormone Releasing Factor, GRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| Hepatitis Virus C NS3 Protease Inhibitor 2 | Ac-DE-Dif-E-Cha-C |
| PEP1 | SGSWLRDVWDWICTVLTDFKTWLQSKLDYKD-NH2 |
| Histone H1-derived Peptide | GGGPATPKKAKKL |
| Histone H2A (1-20) | SGRGKQGGKARAKAKTRSSR |
| Histone H2A (1-20)-GGK(Biotin); biotin-labeled | SGRGKQGGKARAKAKTRSSRGG-K(Biotin) |
| Histone H2A (1-22)-GK(Biotin) | SGRGKQGGKARAKAKSRSSRAG-GK(Biotin)-NH2 |
| Histone H2B (21-41), biotin labeled | AQKKDGKKRKRSRKESYSIYVGG-K(Biotin) |
| Histone H3 (1-8) | ARTKQTAR |
| Histone H3 (73-83) | EIAQDFKTDLR |
| [Lys(Me3)79]-Histone H3(73-83), H3K79(Me3) | EIAQDF-K(Me3)-TDLR |
| [Lys(Ac)79]-Histone H3 (69-89), H3K79(Ac), biotin-labeled | RLVREIAQDF-K(Ac)-TDLRFQSSAV-K(biotin) |
| [Lys(Me1)27/36]-Histone H3 (21-44)-GK(Biotin), H3K27(Me1)K36(Me1) | ATKAAR-K(Me1)-SAPATGGV-K(Me1)-KPHRYRPG-GK(Biotin) |
| [Lys(Me2)27, Lys(Me1)36]-Histone H3 (21-44)-GK(Biotin), H3K27(Me2)K36(Me1), biotin-labeled | ATKAAR-K(Me2)-SAPATGGV-K(Me1)-KPHRYRPGG-K(Biotin) |
| [Lys(Me1)4]-Histone H3 (1-10), H3K4(Me1) | ART-K(Me1)-QTARKS |
| [Lys(Me2)4]-Histone H3 (1-10), H3K4(Me2) | ART-K(Me2)-QTARKS |
| [Lys(Me3)4]-Histone H3 (1-10), H3K4(Me3) | ART-K(Me3)-QTARKS |
| [Lys(Ac)14]-Histone H3 (1-19),H3K14(Ac) | ARTKQTARKSTGG-K(Ac)-APRKQ |
| Histone H3 (1-20), N-Terminal | ARTKQTARKSTGGKAPRKQL |
| [Lys(Ac)9]-Histone H3 (1-20), H3K9(Ac) | ARTKQTAR-K(Ac)-STGGKAPRKQL |
| Histone H3 (1-21), Biotinylated | ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2 |
| Histone H3 (1-21), FAM labeled | ARTKQTARKSTGGKAPRKQLAGG-K(FAM)-NH2 |
| Histone H3 (1-21), N-Terminal | ARTKQTARKSTGGKAPRKQLA |
| [Cit 2/8/17]-Histone H3 (1-21)-GGK(Biotin), amide | A-Cit-TKQTA-Cit-KSTGGKAP-Cit-KQLAGG-K(Biotin)-NH2 |
| [Lys(Ac)4]-Histone H3 (1-21)-GGK(Biotin) | ART-K(Ac)-QTARKSTGGKAPRKQLAGG-K(biotin) |
| [Lys(Me1)4]-Histone H3 (1-21), H3K4(Me1) | ART-K(Me1)-QTARKSTGGKAPRKQLA |
| [Lys(Me2)4]-Histone H3 (1-21), H3K4(Me2) | ART-K(Me2)-QTARKSTGGKAPRKQLA |
| [Lys(Me3)4]-Histone H3 (1-21), H3K4(Me3) | ART-K(Me3)-QTARKSTGGKAPRKQLA |
| [Lys(Me3)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me3), biotin labeled | ART-K(Me3)-QTARKSTGGKAPRKQLA-GGK(Biotin)-NH2 |
| [Lys(Me1)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me1), biotin-labeled | ART-K(Me1)-QTARKSTGGKAPRKQLA-GGK(Biotin) |
| [Lys(Me2)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me2), biotin-labeled | ART-K(Me2)-QTARKSTGGKAPRKQLA-GGK(Biotin) |
| [Lys(Me3)4]-Histone H3 (1-21)-GGK(Biotin), H3K4(Me3), biotin-labeled | ART-K(Me3)-QTARKSTGGKAPRKQLA-GGK(Biotin) |
| [Lys (Me3)4, Lys (Ac)9, pSer10]-Histone H3 (1-21) | ART-K(Me3)-QTAR-K(Ac)-pS-TGGKAPRKQLA |
| [Arg(Me1)8]-Histone H3 (1-21)-K(Biotin), H3R8(Me1), biotin labeled | ARTKQTA-R(Me1)-KSTGGKAPRKQLA-K(Biotin)-NH2 |
| [Arg(Me2a)8]-Histone H3(1-21)-K(Biotin), H3R8(Me2a), biotin-labeled | ARTKQTA-R(Me2a)-KSTGGKAPRKQLA-K(Biotin)-NH2 |
| [Arg(Me2s)8]-Histone H3 (1-21), biotin-labeled | ARTKQTA-R(Me2s)-KSTGGKAPRKQLA-K(Biotin) |
| [Lys(Ac)9]-Histone H3 (1-21), H3K9(Ac) | ARTKQTAR-K(Ac)-STGGKAPRKQLA |
| [Lys(Ac)9]-Histone H3 (1-21)-NH2, H3K9(Ac), biotin-labeled, amide | ARTKQTAR-K(Ac)-STGGKAPRKQLA-GGK(Biotin)-NH2 |
| [Lys(Ac)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Ac), biotin-labeled | ARTKQTAR-K(Ac)-STGGKAPRKQLA-GGK(Biotin) |
| [Lys(Ac)9/14]-Histone H3 (1-21)-GGK(Biotin), H3K9/14(Ac), biotin-labeled | ARTKQTAR-K(Ac)-STGG-K(Ac)-APRKQLA-GGK(Biotin) |
| [Lys(Me1)9]-Histone H3 (1-21), biotin-labeled | ARTKQTAR-K(Me1)-STGGKAPRKQLA-K(Biotin) |
| [Lys(Me1)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me1), biotin-labeled | ARTKQTAR-K(Me1)-STGGKAPRKQLA-GGK(Biotin) |
| [Lys(Me1)9]-Histone H3 (1-21)-GGK(Biotin); H3K9(Me1), biotin-labeled, amide | ARTKQTAR-K(Me1)-STGGKAPRKQLA-GGK(Biotin)-NH2 |
| [Lys(Me2)9]-Histone H3 (1-21) | ARTKQTAR-K(Me2)-STGGKAPRKQLA |
| [Lys(Me2)9]-Histone H3 (1-21)-K(Biotin), H3K9(Me2), biotin labeled | ARTKQTAR-K(Me2)-STGGKAPRKQLA-K(Biotin) |
| [Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me2), biotin-labeled | ARTKQTAR-K(Me2)-STGGKAPRKQLA-GGK(Biotin) |
| [Lys(Me2)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me2), biotin-labeled, amide | ARTKQTAR-K(Me2)-STGGKAPRKQLA-GGK(Biotin)-NH2 |
| [Lys(Me3)9]-Histone H3 (1-21), H3K9(Me3) | ARTKQTAR-K(Me3)-STGGKAPRKQLA |
| [Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me3), biotin-labeled | ARTKQTAR-K(Me3)-STGGKAPRKQLA-GGK(Biotin) |
| [Lys(Me3)9]-Histone H3 (1-21)-GGK(Biotin), H3K9(Me3), biotin-labeled, amide | ARTKQTAR-K(Me3)-STGGKAPRKQLAGG-K(Biotin)-NH2 |
| [pSer10]-Histone H3 (1-21)-GGK(Biotin); H3pS10, biotin-labeled | ARTKQTARK-pS-TGGKAPRKQLA-GGK(Biotin)-NH2 |
| [pSer10), Lys(Ac)14]-Histone H3 (1-21)-GGK(Biotin), biotin-labeled | ARTKQTARK-pS-TGG-K(Ac)-APRKQLAGGK(Biotin) |
| [pThr11]-Histone H3(1-21)-GGK(Biotin), H3pT11, biotin-labeled | ARTKQTARKS-pT-GGKAPRKQLAGG-K(Biotin)-NH2 |
| [Lys(Ac)14]-Histone H3 (1-21)-GGK(Biotin), H3K14(Ac), biotin-labeled | ARTKQTARKSTGG-K(Ac)-APRKQLA-GGK(Biotin) |
| [Arg(Me1)17]-Histone H3 (1-21)-GGK(Biotin), H3R17(Me1), biotin-labeled | ARTKQTARKSTGGKAP-R(Me1)-KQLA-GGK(Biotin)-NH2 |
| [Cit17]-Histone H3 (1-21)-GGK(Biotin) | ARTKQTARKSTGGKAP-Cit-KQLAGG-K(Biotin) |
| [Lys(Ac)18]-Histone 3 (1-21)-GGK(Biotin); H3K18(Ac), biotin-labeled | ARTKQTARKSTGGKAPR-K(Ac)-QLA-GGK(Biotin)-NH2 |
| [Lys(Me1)18]-Histone H3 (1-21)-GGK(Biotin), H3K18(Me1), biotin-labeled | ARTKQTARKSTGGKAPR-K(Me1)-QLA-GGK(Biotin)-NH2 |
| [Lys(Me2)18]-Histone H3 (1-21)-GGK(Biotin), H3K18(Me2), biotin-labeled | ARTKQTARKSTGGKAPR-K(Me2)-QLA-GGK(Biotin)-NH2 |
| [Lys(Ac)9]-Histone H3 (1-24), H3K9(Ac) | ARTKQTAR-K(Ac)-STGGKAPRKQLATKA |
| [Lys(Ac)14/18/23]-Histone H3 (1-24)-GGK(Biotin) | ARTKQTARKSTGG-K(Ac)-APR-K(Ac)-QLAT-K(Ac)-AGG-K(Biotin) |
| Histone H3 (1-25), amide | ARTKQTARKSTGGKAPRKQLATKAA-NH2 |
| [Lys(Me3)4]-Histone H3 (1-25); H3K4(Me3) | ART-K(Me3)-QTARKSTGGKAPRKQLATKAA-NH2 |
| [Lys(Ac)14/18/23/27]-Histone H3 (1-30)-GGK(Biotin) | ARTKQTARKSTGG-K(Ac)-APR-K(Ac)-QLAT-K(Ac)-AAR-K(Ac)-SAPGG-K(Biotin) |
| Histone H3(1-35) | ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGV |
| Histone H3 (1-50)-GGK(Biotin), biotin-labeled | ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREGG-K(Biotin) |
| [Lys(Me1)9]-Histone H3 (3-17), H3K9(Me1) | TKQTAR-K(Me1)-STGGKAPR |
| [Lys(Me2)9]-Histone H3 (3-17), H3K9(Me2) | TKQTAR-K(Me2)-STGGKAPR |
| [Lys(Me3)9]-Histone H3 (3-17), H3K9(Me3) | TKQTAR-K(Me3)-STGGKAPR |
| Histone H3 (5-23) | QTARKSTGGKAPRKQLASK |
| [Lys(Ac)14]-Histone H3 (9-19), H3K14(Ac) | KSTGG-K(Ac)-APRKQ |
| [Arg(Me2a)26]-Histone H3 (15-36)-GGK(Biotin), H3R26(Me2a), biotin labeled | APRKQLATKAA-R(Me2a)-KSAPATGGVKGG-K(Biotin) |
| [Lys(Me2)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Me2), biotin-labeled | ATKAARKSAPATGGV-K(Me2)-KPHRYRPG-GK(Biotin) |
| [Lys(Me3)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Me3), biotin-labeled | ATKAARKSAPATGGV-K(Me3)-KPHRYRPG-GK(Biotin) |
| Histone H3 (21-44) | ATKAARKSAPATGGVKKPHRYRPG |
| Histone H3 (21-44)-GK(Biotin), biotin-labeled | ATKAARKSAPATGGVKKPHRYRPG-GK(Biotin) |
| Histone H3 (21-44)-GK(Biotin), biotin-labeled, amide | ATKAARKSAPSTGGVKKPHRYRPG-GK(Biotin)-NH2 |
| [Lys(Ac)27]-Histone 3 (21-44)-GK(Biotin); H3K27(Ac), biotin-labeled | ATKAAR-K(Ac)-SAPSTGGVKKPHRYRPG-GK(Biotin)-NH2 |
| [Lys(Me1)23]-Histone H3 (21-44)-GK(Biotin); H3K23(Me1), biotin-labeled | AT-K(Me1)-AARKSAPSTGGVKKPHRYRPG-GK(Biotin)-NH2 |
| [Lys(Ac)27]-Histone H3 (21-43)-GGK(Biotin), H3K27(Ac), biotin-labeled | ATKAAR-K(Ac)-SAPATGGVKKPHRYRPGG-K(Biotin) |
| [Lys(Me1)27]-Histone H3 (21-44)-GK(Biotin), H3K27(Me1), biotin-labeled | ATKAAR-K(Me1)-SAPATGGVKKPHRYRPG-GK(Biotin) |
| [Lys(Me2)27]-Histone H3 (21-44)-GK(Biotin), H3K27(Me2), biotin-labeled | ATKAAR-K(Me2)-SAPATGGVKKPHRYRPG-GK(Biotin) |
| [Lys(Me3)27]-Histone H3 (21-44)-GK(Biotin), H3K27(Me3), biotin-labeled | ATKAAR-K(Me3)-SAPATGGVKKPHRYRPG-GK(Biotin) |
| [Lys(Ac)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Ac), biotin-labeled | ATKAARKSAPATGGV-K(Ac)-KPHRYRPGG-K(Biotin) |
| [pSer28]-Histone H3 (21-44)-GK (Biotin), biotin-labeled | ATKAARK-pS-APATGGVKKPHRYRPGG-K(Biotin) |
| [Cit26]-Histone H3 (21-44)-GGK(Biotin) | ATKAA-Cit-KSAPATGGVKKPHRYRPGGG-K(Biotin) |
| [Lys(Ac)23]-Histone H3 (21-44)-GK(Biotin); H3K23(Ac), biotin-labeled | AT-K(Ac)-AARKSAPATGGVKKPHRYRPGG-K(Biotin) |
| [Lys(Me1)36]-Histone H3 (21-44)-GK(Biotin), H3K36(Me1), biotin-labeled | ATKAARKSAPATGGV-K(Me1)-KPHRYRPG-GK(Biotin) |
| Histone H3 (23-34) | KAARKSAPATGG |
| [Lys(Ac)27]-Histone H3 (23-34), H3K27(Ac) | KAAR-K(Ac)-SAPATGG |
| [Lys(Me1)27]-Histone H3 (23-34), H3K27(Me1) | KAAR-K(Me1)-SAPATGG |
| [Lys(Me2)27]-Histone H3 (23-34), H3K27(Me2) | KAAR-K(Me2)-SAPATGG |
| [Lys(Me3)27]-Histone H3 (23-34), H3K27(Me3) | KAAR-K(Me3)-SAPATGG |
| [Lys(Me3)27-Histone H3 (23-34)-GGK(Biotin) | KAAR-K(Me3)-SAPATGGGG-K(Biotin) |
| [Lys(Me1)36]-Histone H3 (26-46)-K(Biotin), H3K36(Me1), Schizosaccharomyces octosporus | RKAAPATGGV-K(Me1)-KPHRYRPGTV-K(BIOTIN) |
| [Lys(Me2)36]-Histone H3 (26-46), H3K36(Me2) | RKAAPATGGV-K(Me2)-KPHRYRPGTV-K(BIOTIN) |
| [Lys(Me1)36]-Histone H3 (31-41), H3K36(Me1) | STGGV-K(Me1)-KPHRY |
| [Lys(Me2)36]-Histone H3 (31-41), H3K36(Me2) | STGGV-K(Me2)-KPHRY |
| [Lys(Me3)36]-Histone H3 (31-41), H3K36(Me3) | STGGV-K(Me3)-KPHRY |
| [Lys(Ac)56]-Histone H3 (44-63) | GTVALREIRRYQ-K(Ac)-STELLIR |
| Histone H3 (69-89)-K(Biotin) | RLVREIAQDFKTDLRFQSSAV-K(Biotin) |
| [Lys(Me2)79]-Histone H3 (69-89)-K(Biotin), H3K79(Me2), biotin-labeled | RLVREIAQDF-K(Me2)-TDLRFQSSAV-K(Biotin) |
| [Lys(Me1)79]-Histone H3 (69-89)-K(Biotin), H3K79(Me1), biotin labeled | RLVREIAQDF-K(Me1)-TDLRFQSSAV-K(Biotin) |
| [Lys(Me3)79]-Histone H3 (69-89)-K(Biotin), H3K79(Me3), biotin labeled | RLVREIAQDF-K(Me3)-TDLRFQSSAV-K(biotin) |
| Histone H3 (116-136), C116-136 | KRVTIMPKDIQLARRIRGERA |
| [Lys(Me1)9]-Histone H3 (1-21), H3K9(Me1) | ARTKQTAR-K(Me1)-STGGKAPRKQLA |
| [Lys(Me1)20]-Histone H4 (1-23)-GGK(Biotin), H4K20(Me1), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Me1)-VLR-GGK(Biotin)-NH2 |
| [Lys(Me3)20]-Histone H4 (1-23)-GGK(Biotin), H4K20(Me3), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Me3)-VLR-GGK(Biotin)-NH2 |
| [Lys(Me2)20]-Histone H4 (1-23)-GGK(Biotin), H4K20(Me2), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Me2)-VLR-GGK(Biotin)-NH2 |
| [Lys(Ac)5]-Histone H4 (1-21)-GGK(Biotin), H4K5(Ac), biotin-labeled | Ac-SGRG-K(Ac)-GGKGLGKGGAKRHRKVGG-K(Biotin) |
| [Lys(Ac)16]-Histone H4 (1-21)-GGK(Biotin), H4K16(Ac), biotin-labeled | Ac-SGRGKGGKGLGKGGA-K(Ac)-RHRKVGG-K(Biotin) |
| [Lys(Ac)8]-Histone H4 (1-21)-GGK(Biotin), H4K8(Ac), biotin-labeled | Ac-SGRGKGG-K(Ac)-GLGKGGAKRHRKV-GGK(Biotin) |
| Histone H4 (1-23)-GSGSK, C-terminal biotin-labeled | SGRGKGGKGLGKGGAKRHRKVLRGSGS-K(Biotin) |
| [Lys(Ac)12]-Histone H4 (1-21)-GGK(Biotin), H4K12(Ac), biotin-labeled | Ac-SGRGKGGKGLG-K(Ac)-GGAKRHRKVGG-K(Biotin) |
| Histone H4 (8-25)-WC, amide | KGLGKGGAKRHRKVLRDNWC-NH2 |
| [Lys(Ac)5/8/12/16]-Histone H4 (1-21)-GGK(Biotin), H4K5/8/12/16(Ac), biotin-labeled | SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVGG-K(Biotin) |
| Histone H4 (1-23)-GGK(Biotin), biotin labeled, amide | SGRGKGGKGLGKGGAKRHRKVLRGG-K(Biotin)-NH2 |
| [Lys(Me1)12]-Histone H4(1-21)-GGK(Biotin), H4K12(Me1), biotin-labeled | Ac-SGRGKGGKGLG-K(Me1)-GGAKRHRKVGG-K(Biotin) |
| [Lys(Me3)12]-Histone H4(1-21)-GGK(Biotin), H4K12(Me3), biotin-labeled | Ac-SGRGKGGKGLG-K(Me3)-GGAKRHRKVGG-K(Biotin) |
| [Cit3]-Histone H4 (1-23)-GGK(Biotin) | SG-Cit-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
| [Arg(Me1)3]-Histone H4 (1-23)-GGK(Biotin) | SG-R(Me1)-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
| [Arg(Me2s)3]-Histone H4 (1-23)-GGK(Biotin) | SG-R(Me2s)-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
| [Lys(Ac) 5/8/12/16]-Histone H4 (1-25)-GSGSK(Biotin) | SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVLRDNGSGS-K(Biotin) |
| [Lys(Ac)12]-Histone H4 (1-25)-GSGSK(Biotin); H4K12(Ac), biotin-labeled | SGRGKGGKGLG-K(Ac)-GGAKRHRKVLRDNGSGS-K(Biotin) |
| [Lys(Ac)16]-Histone H4 (1-25)-GSGSK(Biotin); H4K16(Ac), biotin-labeled | SGRGKGGKGLGKGGA-K(Ac)-RHRKVLRDNGSGS-K(Biotin) |
| [Lys(Ac)20]-Histone H4 (1-25)-GSGSK(Biotin); H4K20(Ac), biotin-labeled | SGRGKGGKGLGKGGAKRHR-K(Ac)-VLRDNGSGS-K(Biotin) |
| [Lys(Ac)5]-Histone H4 (1-25)-GSGSK(Biotin); H4K5(Ac), biotin-labeled | SGRG-K(Ac)-GGKGLGKGGAKRHRKVLRDNGSGS-K(Biotin) |
| [Lys(Ac)8]-Histone H4 (1-25)-GSGSK(Biotin); H4K8(Ac), biotin-labeled | SGRGKGG-K(Ac)-GLGKGGAKRHRKVLRDNGSGS-K(Biotin) |
| Histone H4 (1-25)-GSGSK(Biotin) | SGRGKGGKGLGKGGAKRHRKVLRDNGSGS-K(Biotin) |
| [Lys(Ac)12/16]-Histone H4(1-25)-GSGSK(Biotin); H4K12/16(Ac), biotin-labeled | SGRGKGGKGLG-K(Ac)-GGA-K(Ac)-RHRKVLRDNGSGS-K(Biotin) |
| Histone H4 (1-7), N-Terminal | SGRGKGG |
| [Arg(Me2a)3]-Histone H4 (1-23)-GGK(Biotin) | SG-R(Me2a)-GKGGKGLGKGGAKRHRKVLRGG-K(Biotin) |
| [Lys(Ac)12/16, Lys(Me3)20]-Histone H4 (1-25)-GSGSK(Biotin) | SGRGKGGKGLG-K(Ac)-GGA-K(Ac)-RHR-K(Me3)-VLRDNGSGS-K(Biotin) |
| [Lys(Ac)5/8/12/16]-Histone H4 (1-25)-GSGSK | SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-RHRKVLRDNGSGSK |
| [Lys(Me1)20]-Histone H4 (8-30)-WGK(Biotin); H4K20(Me1) (8-30), biotin-labeled | Ac-KGLGKGGAKRHR-K(Me1)-VLRDNIQGIT-WGK(biotin) |
| Histone H4 (8-30)-WGK(Biotin) | Ac-KGLGKGGAKRHRKVLRDNIQGIT-WGK(biotin) |
| [Lys(Me2)20]-Histone H4 (8-30)-WGK(Biotin); H4K20(Me2) (8-30), biotin-labeled | Ac-KGLGKGGAKRHR-K(Me2)-VLRDNIQGITWG-K(biotin) |
| [Lys(Me3)20]-Histone H4 (8-30)-WGK(Biotin); H4K20(Me3) (8-30), biotin-labeled | Ac-KGLGKGGAKRHR-K(Me3)-VLRDNIQGITWG-K(biotin) |
| Histone H4 (1-20), PRMT7 Substrate, M1 | SGRGKGGKGLGKGGAKRHRK-NH2 |
| [Lys(Ac)5]-Histone H4 (1-20), H4K5(Ac) | SGRG-K(Ac)-GGKGLGKGGAKRHRK |
| [Lys(Ac)8]-Histone H4 (1-20), H4K8(Ac) | SGRGKGG-K(Ac)-GLGKGGAKRHRK |
| [Lys(Ac)12]-Histone H4 (1-20), H4K12(Ac) | SGRGKGGKGLG-K(Ac)-GGAKRHRK |
| [Lys(Ac)16]-Histone H4 (1-20), H4K16(Ac) | SGRGKGGKGLGKGGA-K(Ac)-RHRK |
| Histone H4 (1-21)-Lys(Biotin) | Ac-SGRGKGGKGLGKGGAKRHRKVGG-K(Biotin) |
| Histone H4 (1-21), p300/CBP Substrate | SGRGKGGKGLGKGGAKRHRKV |
| [Arg(Me1)3]-Histone H4(1-21)-GGK(Biotin), H4R3(Me1), biotin-labeled | Ac-SG-R(Me1)-GKGGKGLGKGGAKRHRKVGG-K(Biotin) |
| [Arg(Me2a)3]-Histone H4(1-21)-GGK(Biotin), H4R3(Me2a), biotin-labeled | Ac-SG-R(Me2a)-GKGGKGLGKGGAKRHRKVGG-K(Biotin) |
| [Arg(Me2s)3]-Histone H4 (1-21)-GGK(Biotin); H4R3(Me2s) (1-21), biotin-labeled | Ac-SG-R(me2s)-GKGGKGLGKGGAKRHRKV-GGK(biotin) |
| AKT/PKB/Rac-Protein Kinase Substrate [ARKRERTYSFGHHA], Biotinylated | Biotin-ARKRERTYSFGHHA |
| CDK5 Substrate | PKTPKKAKKL |
| Histone deacetylase, HDAC substrate | Ac-RGK(Ac)-AMC |
| C34, gp41 HIV Fragment | WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL |
| Gag Spacer Peptide P1 | HHHHHHIIKIIK |
| Prostatic Acid Phosphatase (248-286), PAP (248-286) | GIHKQKEKSRLQGGVLVNEILNHMKRATQIPSYKKLIMY |
| T20 | Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 |
| Integrin-Binding Site, GRGDNP | GRGDNP |
| Laminin Pentapeptide | YIGSR |
| GALA, Pore-Forming Peptide | WEAALAEALAEALAEHLAEALAEALEALAA |
| Ryanodine receptor 1 (RyR1) (3614-3643); Calmodulin Binding Peptide (CaMBP) | KSKKAVWHKLLSKQRRRAVVACFRMTPLYN |
| Crosstide [GRPRTSSFAEG] | GRPRTSSFAEG |
| Autocamtide-2[KKALRRQETVDAL] | KKALRRQETVDAL |
| Syntide-2[PLARTLSVAGLPGKK] | PLARTLSVAGLPGKK |
| HATPPKKKRK | HATPPKKKRK |
| CK1 Peptide Substrate [pS7] | KRRRAL-pS-VASLPGL |
| Casein Kinase 2 (CK2) Substrate α-subunit | RRRDDDSDDD |
| Glycogen Synthase 1-10, 5-FAM labeled | 5-FAM-PLSRTLSVSS-NH2 |
| Insulin Receptor (1142-1153), pTyr(1146, 1150, 1151) | TRDI-pY-ETD-pY-pY-RK |
| Insulin Receptor (1142-1153), pTyr1146 | TRDI-pY-ETDYYRK |
| Insulin Receptor (1142-1153), pTyr1150 | TRDIYETD-pY-YRK |
| Syk Kinase Peptide Substrate | KEDPDYEWPSAK-NH2 |
| Syk Kinase Peptide Substrate, Biotin labeled | Biotin-KEDPDYEWPSAK-NH2 |
| MBP, MAPK Substrate, Biotinylated | Biotin-APRTPGGRR |
| MBP, MAPK Substrate, Biotinylated, Phosphorylated | Biotin-APR-pT-PGGRR |
| Myosin Regulatory Light Chain MRCL3 (11-24) | KKRPQRATSNVFAM-NH2 |
| pp60(v-SRC) Autophosphorylation Site, Phosphorylated | RRLIEDNE-pY-TARG |
| CREBtide [KRREILSRRPSYR] | KRREILSRRPSYR |
| CREBtide [KRREILSRRPSYR], Phosphorylated, C-term K | KRREILSRRPS-pY-RK |
| Kemptide [LRRASLG] | LRRASLG |
| [Ser25]-PKC (19-31), biotinylated | K(Biotin)-RFARKGSLRQKNV |
| Neurogranin 28-43[AAKIQASFRGHMARKK], Biotinylated-LC | Biotin-LC-AAKIQASFRGHMARKK |
| PKC (Protein Kinase C) Substrate | ERMRPRKRQGSVRRRV |
| PKG Substrate [RKRSRAE], Glasstide | RKRSRAE |
| P70 S6 Kinase Substrate | KKRNRTLTV |
| S6 Kinase Substrate (229-239) | AKRRRLSSLRA |
| S6 Kinase Substrate (229-239), Amide, Biotinalyted | Biotin-AKRRRLSSLRA-NH2 |
| Srctide | GEEPLYWSFPAKKK-NH2 |
| Srctide, biotinylated | Biotin-GEEPLYWSFPAKKK-NH2 |
| Srctide, FAM labeled | 5-FAM-GEEPLYWSFPAKKK-NH2 |
| LKBtide; LKB1/STK11 Substrate Peptide | LSNLYHQGKFLQTFCGSPLYRRR |
| Tyrosine Kinase Peptide 1 [KVEKIGEGTYGVVYK], 5-TMR labeled | KVEKIGEGTYGVVYK |
| Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG], Phosphorylated | RRLIEDAE-pY-AARG |
| Luteinizing Hormone-Releasing Hormone (LH-RH), human | Pyr-HWSYGLRPG-NH2 |
| Cetrorelix Acetate, Cetrotide | Ac-{d-A[3-(2-naphthyl)]}-[d-F(4-Cl)]-{d-A[3-(3-pyridyl)]}-SY-(d-Cit)-LRP-d-A-NH2?Acetate |
| MAPS, Core, 8-Branch | K4K2KA-NH2 |
| [Leu27]-Melan-A, MART 1 (26-35) | ELAGIGILTV |
| Melan-A, MART 1 (26-35) | EAAGIGILTV |
| Melan-A/MART-1 (27-35) | AAGIGILTV |
| MUC1, mucin core | GVTSAPDTRPAPGSTA |
| NDP-MSH, 5-TAMRA-labeled | 5-TMR-SYS-Nle-EHfRWGKPV-NH2 |
| Adeno-Associated Virus Epitope 2 (AAV2) | VPQYGYLTL |
| BDC2.5 mimotope 1040-31 | YVRPLWVRME |
| Dby HY Peptide | NAGFNSNRANSSRSS |
| Eα (52-68) | ASFEAQGALANIAVDKA |
| Glutamic Acid Decarboxylase (GAD65) (524-543), p524-543 | SRLSKVAPVIKARMMEYGTT |
| IL-8 Inhibitor | Ac-RRWWCR-NH2 |
| LCMV (276-286), GP276 | SGVENPGGYCL |
| LCMV gp33-41 | KAVYNFATM |
| LLO190 | NEKYAQAYPNVS |
| Mgp100 (25-33), mouse | EGSRNQDWL |
| NY-ESO-1 (87-111) | LLEFYLAMPFATPMEAELARRSLAQ |
| Uty HY Peptide (246-254), mouse | WMHHNMDLI |
| Plasmepsin V FRET Substrate | Dabcyl-LNKRLLHETQ-EDANS |
| Poly-γ-D-Glutamic Acid Construct | Ac-(γ-e)15-C-NH2 |
| Humanin, HN | MAPRGFSCLLLLTSEIDLPVKRRA |
| MOTS-c | H-MRWQEMGYIFYPRKLR-OH |
| SHLP1 (Small humanin-like peptide 1) | H-MCHWAGGASNTGDARGDVFGKQAG-OH |
| SHLP3 (Small humanin-like peptide 3) | H-MLGYNFSSFPCGTISIAPGFNFYRLYFIWVNGLAKVVW-OH |
| SHLP4 (Small humanin-like peptide 4) | H-MLEVMFLVNRRGKICRVPFTFFNLSL-OH |
| SHLP6 (Small humanin-like peptide 6) | H-MLDQDIPMVQPLLKVRLFND-OH |
| MOG (35-55), mouse, rat | MEVGWYRSPFSRVVHLYRNGK |
| MOG (35-55), human | MEVGWYRPPFSRVVHLYRNGK |
| MOG (89-113), human | RFSDEGGFTCFFRDHSYQEEAAMEL |
| MOG (92-106) | DEGGYTCFFRDHSYQ |
| MBP (4-14), bovine, MBP (3-13), mouse | QKRPSQRSKYL |
| MBP (69-85), guinea pig | YGSLPQKSQRSQDENPV |
| MBP (85-98), guinea pig, MBP (86-99), human, MBP (83-96) mouse | VVHFFKNIVTPRTP |
| MBP (85-106) guinea pig, MBP (86-107), human | VVHFFKNIVTPRTPPPSQGKGR |
| MBP (84-96), mouse, MBP (86-98), guinea pig, MBP (87-99), human | VHFFKNIVTPRTP |
| MBP (88-104), guinea pig, MBP (89-105), human, MBP (86-102), mouse | Ac-FFKNIVTPRTPPPSQGK-NH2 |
| MBP MAPK Substrate | APRTPGGRR |
| Biotin-LC-MBP Derivatized Peptide | Biotin-LC-FFKNIVTPRTPPPSQGK-NH2 |
| Myosin H Chain Fragment, mouse | Ac-RSLKLMATLFSTYASADR |
| Nesfatin-1 (24-53), human | PDTGLYYDEYLKQVIDVLETDKHFREKLQK-NH2 |
| Nesfatin-1 (24-53), mouse | PDTGLYYDEYLKQVIEVLETDPHFREKLQK-NH2 |
| biotin-Neurogranin (48-76), human | Biotin-SGERGRKGPGPGGPGGAGVARGGAGGGPS |
| biotin-Neurogranin (48-76), mouse | Biotin-SGECGRKGPGPGGPGGAGGARGGAGGGPS |
| Neurogranin (48-76), human | SGERGRKGPGPGGPGGAGVARGGAGGGPS |
| Neurogranin (48-76), mouse | SGECGRKGPGPGGPGGAGGARGGAGGGPS |
| Glutamate Receptor Endocytosis Inhibitor, GluR23Y | YKEGYNVYG |
| LCMV GP61 | GLNGPDIYKGVYQFKSVEFD |
| LCMV NP396 H-2Db peptide | FQPQNGQFI |
| MOG (44-54), mouse, human, rat | FSRVVHLYRNG |
| Neuropeptide S, NPS, human | SFRNGVGTGMKKTSFQRAKS |
| Neuropeptide S, NPS, mouse | SFRNGVGSGAKKTSFRRAKQ |
| P0 (180-199) | Peripheral Myelin P0 Protein (180-199), mouse |
| P2 (53-78) | Peripheral Myelin Protein P2 (53-78), bovine |
| Secretoneurin | TNEIVEEQYTPQSLATLESVFQELGKLTGPSNQ |
| IKKγ NEMO Binding Domain (NBD) Inhibitory Peptide | DRQIKIWFQNRRMKWKKTALDWSWLQTE |
| NF-kB Inhibitor, SN50 | AAVALLPAVLLALLAPVQRKRQKLMP |
| Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
| Orexin B, mouse | RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2 |
| [Gla17,21,24]-Osteocalcin (1-49) | YLYQWLGAPVPYPDPL-Gla-PRR-Gla-VC-Gla-LNPDCDELADHIGFQEAYRRFYGPV (Gla=γ-Carboxyglutamic Acid; Disulfide bridge: 23-29) |
| Des-gamma-carboxylated Osteocalcin/Bone Gla Protein | YLYQWLGAPVPYPDPLEPRREVCELNPDCDELADHIGFQEAYRRFYGPV (Disulfide bridge:C23-29) |
| OVA (241-270) | SMLVLLPDEVSGLEQLESIINFEKLTEWTS |
| OVA (257-264) | SIINFEKL |
| OVA (257-264), amide | SIINFEKL-NH2 |
| OVA (257-264), FAM labeled | 5-FAM-SIINFEKL-NH2 |
| OVA (257-264), scrambled, FILKSINE | FILKSINE |
| OVA (323-339) | ISQAVHAAHAEINEAGR |
| OVA (323-339), amide | ISQAVHAAHAEINEAGR-NH2 |
| OVA (323-339), biotin-labeled | Biotin-ISQAVHAAHAEINEAGR |
| OVA (323-339), FITC-labeled | FITC-LC-ISQAVHAAHAEINEAGR |
| OVA (323-339), TAMRA labeled | 5-TAMRA-ISQAVHAAHAEINEAGR |
| OVA (329-337) | AAHAEINEA |
| OVA-A2 Peptide, SAINFEKL, OVA (257-264) Variant | SAINFEKL |
| OVA-G4 Peptide, SIIGFEKL, OVA (257-264) Variant | SIIGFEKL |
| OVA-Q4 Peptide, pQ4, SIIQFEKL, OVA (257-264) Variant | SIIQFEKL |
| OVA-Q4H7 Peptide, pQ4H7, SIIQFEHL, OVA (257-264) Variant | SIIQFEHL |
| OVA-T4 Peptide, SIITFEKL, pT4, OVA (257-264) Variant | SIITFEKL |
| Aquaporin-2 (254-267), pSER261, human | RQSVELH-pS-PQSLPR |
| [Lys(Ac)382]-p53 (361-393), biotin labeled, amide, human | Biotin-LC-GSRAHSSHLKSKKGQSTSRHK-K(Ac)-LMFKTEGPDSD-NH2 |
| [Lys(Ac)382]-p53 (372-389), biotin labeled | Biotin-LC-KKGQSTSRHK-K(Ac)-LMFKTEG |
| p53 (17-26) | ETFSDLWKLL |
| TP53 Q9NP68, p53 Mutant Form (372-389), Lys382 (Ac) | KKGQSTSRHK-K(Ac)-LMFKTEG |
| Parathyroid Hormone (1-13) | SVSEIQLMHNLGK |
| Parathyroid Hormone (1-34), human | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF |
| Parathyroid Hormone (1-34), human, biotinylated | Biotin-SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF |
| Parathyroid Hormone (1-34)-Lys(Biotin), human | SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFK(Biotin) |
| TIP 39, Tuberoinfundibular Neuropeptide | SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
| Ala-γ-D-Glu-DAP | A-(γ-e)-DAP |
| Keratin K18-C | RPVSSAApSVYAGAC |
| Threonine Phosphopeptide,PKC Substrate 4, phosphorylated | KR-pT-IRR |
| UOM9, PKC Substrate, phosphorylated | KRP-pS-QRHGSKY-NH2 |
| Phytochelatin 2, PC2 | (γE-C)2-G |
| Phytochelatin 3, PC3 | (γE-C)3-G |
| Phytochelatin 4, PC4 | (γE-C)4-G |
| Phytochelatin 5, PC5 | (γE-C)5-G |
| Phytochelatin 6, PC6 | (γE-C)6-G |
| PrP (106-126) | KTNMKHMAGAAAAGAVVGGLG |
| Calpain Inhibitor Peptide, B27-WT | DPMSSTYIEELGKREVTIPPKYRELLA |
| [Ser140]-PLP (139-151) | HSLGKWLGHPDKF |
| PLP (139-151) | HCLGKWLGHPDKF |
| PLP (178-191) | NTWTTCQSIAFPSK |
| PLP (180-199) | WTTCQSIAFPSKTSASIGSL |
| ε-V1-2, ε-PKC Inhibitor | EAVSLKPT |
| Abltide | KKGEAIYAAPFA-NH2 |
| AMARA peptide | AMARAASAAALARRR |
| Bovine β-Casein, monophosphopeptide | FQ-pS-EEQQQTEDELQDK |
| Cathepsin D and E FRET Substrate | Mca-GKPILFFRLK(Dnp)-r-NH2 |
| Cathepsin K substrate | Abz-HPGGPQ-EDDnp |
| CDK7/9 tide | YSPTSPSYSPTSPSYSPTSPSKKKK |
| DNA-PK Substrate | EPPLSQEAFADLWKK |
| epsilon-V1-2, epsilon-PKC Inhibitor, Cys-conjugated | EAVSLKPTC |
| Erktide | IPTTPITTTYFFFK |
| Forkhead derived peptide, Woodtide | KKISGRLSPIMTEQ-NH2 |
| GSK3 Substrate, a, b subunit | RAAVPPSPSLSRHSSPHQSEDEEE |
| IRS1-derived peptide | KKSRGDYMTMQIG-NH2 |
| Jak3tide | GGEEEEYFELVKKKK |
| MLC-derived peptide | KKRPQRRYSNVF |
| Myristolated PKC Zeta, Pseudosubstrate (ZIP) | Myr-SIYRRGARRWRKL |
| Myristolated PKC Zeta, Pseudosubstrate ZIP, Scrambled | Myristoyl-RLYRKRIWRSAGR |
| PDKtide | KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC |
| Psi-RACK, epsilon-C2/V1 (82-92), epsilon PKC (82-92), C2 Domain | HDAPIGYD |
| RS domain derived peptide | GRSRSRSRSR |
| S3 Fragment, ADF/cofilin | MASGVMVSDDVVKVFN |
| SAMS Peptide | HMRSAMSGLHLVKRR-NH2 |
| Src Optimal Peptide Substrate | AEEEIYGEFEAKKKK |
| Renin FRET Substrate I | DABCYL-g-Abu-IHPFHLVIHT-EDANS |
| Renin Substrate, human | DRVYIHPFHLVIHN |
| IRBP (1-20), human | GPTHLFQPSLVLDMAKVLLD |
| IRBP derived peptide, R16 | ADGSSWEGVGVVPDV |
| IRBP, Interphotoreceptor Retinoid Binding Protein Fragment | SGIPYIISYLHPGNTILHVD |
| GRGDS | GRGDS |
| GRGDSP | GRGDSP |
| GRGDSPK | GRGDSPK |
| GRGDTP | GRGDTP |
| Prototype of RGD-containing peptide, FITC-labeled | FITC-LC-GRGDSP |
| RGDS | RGDS |
| Prosaptide TX14(A) | TaLIDNNATEEILY |
| Dyrktide | RRRFRPASPLRGPPK |
| JAG-1 (188-204), Jagged-1 (188-204), Notch Ligand, DSL Peptide | CDDYYYGFGCNKFCRPR |
| M13 Skeletal Muscle Myosin Light Chain Kinase Peptide, SK-MLCK M13 | KRRWKKNFIAVSAANRFKKISSSGAL |
| Pannexin-1 (Panx1), Mimetic Blocking Peptide | WRQAAFVDSY |
| Scrambled Jag1 | RCGPDCFDNYGRYKYCF |
| Steroid Receptor Co-Factor Peptide | LTERHKILHRLLQE |
| Steroid Receptor Coactivator-1 (SRC-1), (676-700), biotin labeled | Biotin-CPSSHSSLTERHKILHRLLQEGSPS |
| Steroid Receptor Coactivator-1, SRC-1 (686-700) | RHKILHRLLQEGSPS |
| TET 830 modified/T-helper epitope from tetanus toxoid | AQYIKANSKFIGITEL |
| TIF2 (740-753), Transcriptional Intermediary Factor 2 (740-753) | KENALLRYLLDKDD |
| W Peptide, WKYMVm-NH2 | WKYMVm-NH2 |
| WRW4, Formyl Peptide Receptor-Like 1 (FPRL1) Antagonist | WRWWWW |
| Spexin (36-49), amidated, human/mouse/rat | NWTPQAMLYLKGAQ-NH2 |
| Spexin-2 (53-70), amidated, human/mouse/rat | FISDQSRRKDLSDRPLPE-NH2 |
| Spexin-2 (53-70), human/mouse/rat | FISDQSRRKDLSDRPLPE |
| 3 x Hemagglutinin (HA) Tag | MEYPYDVPDYAAEYPYDVPDYAAEYPYDVPDYAAKLE |
| DYKDDDDK | DYKDDDDK |
| Glu-Glu epitope Tag | EYMPME |
| HA 12CA5 Epitope | CYPYDVPDYA |
| HA peptide | YPYDVPDYA |
| Hexa His | HHHHHH |
| Rhodopsin Epitope Tag | TETSQVAPA |
| V5 Epitope Tag | GKPIPNPLLGLDST |
| Tau Peptide (45-73) (Exon 2/Insert 1 domain) | ESPLQTPTEDGSEEPGSETSDAKSTPTAE |
| Tau Peptide (244-274) (Repeat 1 domain) | Ac-QTAPVPMPDLKNVKSKIGSTENLKHQPGGGK |
| Tau Peptide (275-305) (Repeat 2 domain) | VQIINKKLDLSNVQSKCGSKDNIKHVPGGGS |
| Tau Peptide (306-336) (Repeat 3 domain) | VQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQ |
| Tau Peptide (337-368) (Repeat 4 domain) | VEVKSEKLDFKDRVQSKIGSLDNITHVPGGGN |
| [Ser(OGlcNAc)]400-KWK-Tau (388-411)-KK(Biotin)-NH2 | KWKHGAEIVYKSPVV-S(OGlcNAc)-GDTSPRHLSNVK-K(biotin)-NH2 |
| Thrombin Receptor Agonist,amide (SFLLR-NH2) | SFLLR-NH2 |
| Thrombin Receptor Agonist (FLLRN) | FLLRN |
| STAL-2 | SFLLRN-NH2 |
| Scrambled TRAP Fragment | FSLLRN-NH2 |
| SLLK, Control Peptide for TSP1 Inhibitor | SLLK-NH2 |
| ω-Conotoxin GVIA | CKS(Hyp)GSSCS(Hyp)TSYNCCRSCN(Hyp)YTKRCY-NH2 |
| Caloxin 1b1 | TAWSEVLHLLSRGGG |
| Caloxin 2A1 | VSNSNWPSFPSSGGG |
| Caloxin 3A1 | WSSTSSVSAPLEFGGGGSAK |
| Conantokin G | GE(Gla)(Gla)LQ(Gla)NQ(Gla)LIR(Gla)KSN-NH2 |
| Delta-Toxin (1-26), Staphylococcus aureus | MAQDIISTIGDLVKWIIDTVNKFTKK |
| Tetanus Toxin (830-844) | QYIKANSKFIGITEL |
| [Lys(Ac)40]-Ac-a-Tubulin (29-50)-WGK(Biotin); TubK40(Ac)-WGK, biotin-labeled | Ac-GIQPDGQMPSD-K(ac)-TIGGGDDSFNWG-K(biotin) |
| B8R (20-27) | TSYKFESV |
| CKS-17 (dimer), MN10021 | LQNRRGLDLLFLKEGGLC (dimer) |
| CMV pp65 peptide | SVLGPISGHVLKAVF |
| HSV-gB2 (498-505) | SSIEFARL |
| Human Papillomavirus (HPV) E7 protein (49-57) | RAHYNIVTF |
| Influenza A NP (366-374) Strain A/NT/60/68 | ASNENMDAM |
| Influenza HA (307-319) | PKYVKQNTLKLAT |
| Influenza Matrix Protein (62-70), MP (62-70) | GFVFTLTVPSER |
| Influenza NP (147-155) | TYQRTRALV |
| Influenza Virus Nucleoprotein (311-325) | QVYSLIRPNENPAHK |
| IV9 (476-484), HIV-1 RT Epitope | ILKEPVHGV |
| LCMV GP (61-80) | GLKGPDIYKGVYQFKSVEFD |
| Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (33-41), LCMV GP1, gp 33 (33-41) | KAVYNFATC |
| PA (224-233), Influenza | SSLENFRAYV |
| Plasmodium falciparum Circumsporozoite Protein, (6NANP) PfCSP | NANPNANPNANPNANPNANPNANPC |
| VSV-G Peptide | YTDIEMNRLGK |
| (Des-His⁶)-ACTH (1-24) (human, bovine, rat) | SYSMEFRWGKPVGKKRRPVKVYP |
| Acetyl-ACTH (3-24) (human, bovine, rat) | Ac-SMEHFRWGKPVGKKRRPVKVYP |
| (Des-Glu⁵)-ACTH (1-24) (human, bovine, rat) | SYSMHFRWGKPVGKKRRPVKVYP |
| Acetyl-ACTH (7-24) (human, bovine, rat) | Ac-FRWGKPVGKKRRPVKVYP |
| ACTH (2-24) (human, bovine, rat) | YSMEHFRWGKPVGKKRRPVKVYP |
| (Des-Ser3)-ACTH (1-24) (human, bovine, rat) | SYMEHFRWGKPVGKKRRPVKVYP |
| Acetyl-ACTH (2-24) (human, bovine, rat) | Ac-YSMEHFRWGKPVGKKRRPVKVYP |
| Endo-4a-Glu-ACTH (1-24) (human, bovine, rat) | SYSMEEHFRWGKPVGKKRRPVKVYP |
| Acetyl-ACTH (4-24) (human, bovine, rat) | Ac-MEHFRWGKPVGKKRRPVKVYP |
| ACTH (3-24) (human, bovine, rat) | SMEHFRWGKPVGKKRRPVKVYP |
| ACTH (1-14) | SYSMEHFRWGKPVG |
| ACTH (1-16), human | SYSMEHFRWGKPVGKK |
| α-MSH (4-10), ACTH (4-10), human | MEHFRWG |
| ACTH (11-24) | KPVGKKRRPVKVYP |
| ACTH (22-39) | VYPNGAEDESAEAFPLEF |
| ACTH (1-13), human | SYSMEHFRWGKPV |
| ACTH (1-4) | SYSM |
| ACTH (1-39) (mouse, rat） | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF |
| N-Acetyl-ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR |
| R-E-D-V | REDV |
| Procollagen Type I (212-216) | KTTKS |
| Collagen Type I α1 chain (502-516) | H-Gly-Phe-Hyp-Gly-Glu-Arg-Gly-Val-Glu-Gly-Pro-Hyp-Gly-Pro-Ala-NH₂ |
| Ac-Pro-Gly-Pro (PGP) | Ac-PGP |
| Annexin A1 (1-25) (dephosphorylated) (human) | Ac-AMVSEFLKQAWFIENEEQEYVQTVK |
| Neural-Cadherin (76-85) amide (chicken) | LRAHAVDVNG-NH₂ |
| Osteoblast-Adhesive Peptide | KRSR |
| α₂β₁ Integrin Recognition Sequence | DGEA |
